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4. LR-LPJ      :  Local resection of head and Longitudinal pancreaticojejunostomy 
5. PG             :  Pancreaticogastrostomy  
6. PD              :  Pancreaticoduodenectomy 
7.. PPPD          :  Pylorus preserving pancreaticoduodenectomy 
8. DPRHP       :   Duodenum preserving resection of head of pancreas 
9.  MPD          :  Main pancreatic duct 
10. TCP           :  Tropical chronic pancreatitis 
11. ACP           :  Alcoholic chronic pancreatitis 
12. ERCP         :  Endoscopic retrograde cholangiopancreatography 
13. MRCP      :  Magnetic resonance cholangiopancreatography 
14. ESWL       :  Extracorporeal shock wave lithotripsy 
15. PA            :   Pseudoaneurysm 
16. OHA         :  Oral hypoglycemic agents 
17. UTI           :  Urinary tract infection 
18. GI              :  Gastrointestinal 
19. OR             :  Odds ratio 
20. CI               :  Confidence interval 
21. CP               :  Chronic pancreatitis 
22. CRISP3        : Cysteine-rich secretory protein-3 
 
 
 
 
 
 
CONTENTS 
 
                   PAGE NO. 
 
 
1. INTRODUCTION                                                                              1  
 
 
2. REVIEW OF LITERATURE       4 
 
 
3. AIM OF THE STUDY                                                                      31 
 
 
4. PATIENTS AND METHODS                                                           32 
 
 
5. RESULTS                                                                                           34 
 
 
6. DISCUSSION                                                                                     55 
 
 
7. SUMMARY                                                                                       67 
 
 
8. CONCLUSION                                                                                  68 
 
 
9.  REFERENCES                                                                                 69 
 
 
10. ABBREVIATION        
 
 
11. PROFORMA 
 
 
12. MASTER CHART 
DECLARATION 
 
I,  Dr.  A.  SIVASANKAR, solemnly declare that the dissertation titled 
“OUT COME OF SURGERY FOR CHRONIC CALCIFIC 
PANCREATITIS” was done by me at Government Stanley Medical 
College Hospital, Chennai – 1 during the academic year 2003 – 2006 
under the guidance and supervision of my chief, Prof. R.SURENDRAN, 
M.N.A.M.S., M.Ch. 
 This dissertation is submitted to The Tamilnadu Dr. M.G.R. 
Medical University, Chennai towards the partial fulfillment of 
requirement for the award of M.Ch. degree branch VI in Surgical 
Gastroenterology. 
 
 
 
Place : Chennai  Dr. A. SIVASANKAR 
Date  : 28.10.2005 
 
 
 
 
 
 
 
 INTRODUCTION 
 
The management of patients with chronic pancreatitis remains a difficult and challenging problem. The most common 
cause of chronic pancreatitis in western countries is chronic alcohol abuse, opposed to the tropical chronic pancreatitis, commonest 
cause in tropical countries.  Tropical chronic pancreatitis is a unique form of chronic nonalcoholic pancreatitis, which is limited to the 
tropical developing countries. Patients present at a young age with severe abdominal pain, weight loss and insulin requiring diabetes. 
Recently, gene mutations, which lead to hereditary and idiopathic chronic pancreatitis, have also been reported 1.  Patients 
come to the doctor with clinical symptoms such as maldigestion, severe weight loss, recurrent severe upper abdominal pain and 
therefore, a greatly impaired quality of life. Pain is a predominant symptom in chronic pancreatitis.  Later in course of the disease, 
exocrine and endocrine insufficiency may develop.  The pain of chronic pancreatitis patients may prove difficult to control, and 
addiction to analgesics-opioids is not uncommon. 
The therapy for chronic pancreatitis consists primarily of conservative and symptom related treatment but long-term 
follow-up studies have demonstrated that about 50% of the patients will undergo surgical treatment at sometime in the course of the 
disease 1.  
Before 1980, pancreatic surgery was associated with an operative mortality rate of up to 25% and the results of surgery 
were unpredictable, with many patients continuing to suffer from severe pain often associated with marked endocrine and exocrine 
insufficiency 2.  Although conservative treatment may be successful in some patients with chronic pancreatitis if spontaneous 
remission of pain occurs, its timing is unpredictable and the patient may lose valuable years of life 2.  
 The principal indication for surgery in chronic pancreatitis is intractable pain, which prevents the patient from leading a 
normal life.  Less frequently, surgery is indicated for the treatment of complications of chronic pancreatitis including pseudocyst, 
pancreatic fistulae, splenic vein thrombosis, bleeding pseudoaneurysms, and duodenal or biliary obstruction. Additionally the 
exclusion of pancreatic cancer is sometimes not possible even with all the diagnostic procedures available, so that only surgical 
resection can bring a definite answer. 
Controversy still exists regarding the optimal timing of surgery in these patients, but by the time they are referred to the 
surgeon, patients are often in a state of opiate and alcoholic addiction, undernutrition and sometimes diabetes or exocrine insufficiency 
3.  
Recently some studies have shown that surgery has a positive influence on the course of the disease, postponing the final 
“burnout” of the pancreas and the consequent appearance of exocrine and endocrine insufficiency 1. Therefore, it is of great clinical 
importance in the treatment of chronic pancreatitis to address the above mentioned problems surgically before the disease has 
progressed to an advanced stage in which the exocrine and endocrine function is completely lost. 
The ideal operation should provide the best long-term results with minimal functional impairment. However, the optimal 
surgical technique has never been established.  Even among specialist the choice between pancreatic resection and a more 
conservative approach is controversial.  Two main types of operation have been developed based on different theories of pain 
pathogenesis.  The drainage approach is based on the hypothesis of ductal and/or parenchymal hypertension. The resection approach is 
based on the hypothesis of local inflammation and perineuritis. Drainage procedures include Puestow procedure, longitudinal 
pancreaticojejunostmy, pancreaticogastrostomy and local resection and longitudinal pancreaticojejunostomy (LR-LPJ). Resectional 
procedures include distal pancreatectomy, central pancreatectomy, Duodenum preserving pancreatic head resection (Beger procedure) 
and proximal pancreatectomy - Whipple procedure or pylorus-preserving pancreaticoduodenectomy. Operations may be associated 
with a better long-term outcome and with a minimal mortality rate in specialist units. Several centers report an operative mortality rate 
below 5 percent for pancreaticoduodenectomy, including a number of institutions with no perioperative deaths in large series of 
patients.  Postoperative morbidity, however, remains high after these procedures although most complications are amenable to 
treatment.  
Operations can be tailored to the particular pattern of disease in an individual patient, but clear guidelines are lacking. 
Moreover, the impact of surgical intervention on the natural history is not yet well understood. Theoretically, improvement of 
pancreatic function may occur after drainage procedure. After resection, pancreatic function is known to deteriorate 1.Given that 
chronic pancreatitis is basically a progressive lesion of pancreatic parenchyma, and that a significant part of this group of patients 
represents a sector of people living on the peripheries of society, who consume heavy amounts of alcohol or addict to narcotics and 
lead unfortunately self-destructive lives, the initial promising surgical results have usually deteriorated on a long-term basis. The late 
mortality rate is high, ranging between 20-40% and is similar to that of some malignant disease 6. Due to these factors and the poor 
compliance of these patients, results covering long-term follow-up period are few and far between literature. 
 
 
REVIEW OF LITERATURE 
 
The main purpose of operative management of chronic pancreatitis is to relieve symptorns and to treat complications of the 
disease.  The main indication for elective operation is to alleviate pain, the pathophysiology of which is not clearly understood.   Some 
studies, however, have associated pain with increased ductal pressure4, which is the result of obstruction either by stone or by 
stricture.  This explains why duct decompression has been successful in relieving chronic pain. 
Recently, it has been shown that resection of head of pancreas (pacemaker of the 
disease 5 which harbors ductal and / or parenchymal pathologies in 95 % of patients with 
chronic pancreatitis) effectively relieves pain.  Realizing this, the surgeon is faced with 
the decision to choose an optimal procedure for the patient.  It should provide pain 
control and quality of life while being safe and free of side effects. 
 
NATURAL HISTORY:  
 
 The natural history of pain in patients with chronic pancreatitis has been evaluated primarily by retrospective 
observational studies 6, 7. These studies have included patients with heterogeneous etiologies of pancreatitis and a wide array of 
potential manifestations of disease. Although insight can be derived from them, care should be used when drawing firm conclusions. 
Most of these studies have suggested that the pain associated with chronic pancreatitis diminishes with time. There is a debate; 
however, regarding the time it takes for pain to abate, whether this occurs in a majority of patients with uncomplicated disease, and 
whether pain cessation inversely parallels exocrine pancreatic dysfunction. Ammann et al 8 in a study of predominantly alcohol-
induced pancreatitis found that 85% of these patients had cessation of pain after a median of 4.5 years, and this pain relief was not 
altered by surgical intervention. This study also found that pain relief was associated with deterioration of pancreatic function and the 
onset of pancreatic calcification. There was a wide range of time to pain cessation, however, among patients whose pain eventually 
abated (0 to 18 years). Also, 50% to 60% of patients had their last episode of pain despite the presence of pancreatic calcifications. 
The majority of patients who had pain despite having pancreatic calcification had pancreatic pseudocysts. In a second study, Lankisch 
et al 6 found that after a median follow-up of 11.3 years, significantly fewer patients had painful episodes, but the majority of patients 
still experienced pain. Similarly, the overall numbers of patients experiencing pain relief were significantly greater if patients 
developed pancreatic exocrine insufficiency or pancreatic calcifications. The majority of patients who had exocrine insufficiency or 
pancreatic calcification, however, continued to experience pain. Interestingly, pain relief could also not be predicted by the presence of 
pancreatic duct abnormalities. This study also showed that there was no difference in the long-term pain course between patients who 
were operated on and those who were not. In the short-term, 89% of patients who underwent surgery experienced relief of pain. The 
comparison of patients who underwent surgery and those who did not should be taken with caution in both of these studies because 
these groups may not have been comparable, and the surgical procedures used in the majority of patients are not necessarily standard 
presently.  These studies also mixed patients undergoing surgery for uncomplicated and complicated chronic pancreatitis (i.e., 
pseudocysts). A third study by Layer et al 7 also found that the frequency and severity of pain  decreased with time, but that this 
decrease in pain was independent of exocrine insufficiency or pancreatic calcification. The etiology of the chronic pancreatitis affected 
the course of pain in this study. Patients with early onset idiopathic chronic pancreatitis were more likely to have severe pain as an 
initial symptom than patients with late-onset idiopathic or alcohol-induced chronic pancreatitis. 
 In general, although pain may decrease over time in patients with chronic pancreatitis, this should not be relied upon, 
especially in patients with severe discomfort. Medical and interventional therapies designed to diminish and expedite pain relief 
should be thoroughly investigated. Although development of exocrine insufficiency and pancreatic calcification may be associated 
with pain relief, there is no clear evidence that this association is causal. 
 
 
PANCREATIC DUCT DECOMPRESSION PROCEDURES: 
 
 
 The assumption that ductal ectasia, secondary to obstruction or stenosis of the 
pancreatic ductal system is indicative of intraductal hypertension constituted the basis for 
pancreatic ductal decompression at the beginning of the last century. 
 Jalleh et al, in a study to determine the contribution of parenchymal hypertension 
to pain, pancreatic tissue pressures were measured intraoperatively in patients with 
chronic pancreatitis undergoing pancreatic surgery, it was found that the pressure (mean 
± s.e.m) was substantially elevated in all regions of the pancreas compared with reference 
subjects: head (257 ± 59 versus 19 ± 5 mm Hg, p <0.05), body (201 ± 51 versus 13 ± 6 
mm Hg, p < 0.05) and tail (161 ± 45 versus 11 ± 3 mm Hg, p <0.05). Elevation was 
greater in areas of calcific disease (281-383 mm Hg) than in non-calcific disease (81-120 
mm Hg, p < 0.05). The greatly increased tissue pressures in chronic pancreatitis, 
especially in the presence of calcification, suggest a possible ‘compartment syndrome’.9   
 After the original reports by Du Val and Zollinger, the technique for surgical 
decompression of the pancreatic ductal system in patients with chronic pancreatitis was 
modified first by Puestow and Gillespy and later to the longitudinal 
pancreaticojejunostorny proposed by Partington and Rochelle. Because the low surgical 
morbidity and mortality of pancreatic duct internal drainage and the good early results 
achieved, primary ductal decompression became the gold standard treatment of pain in 
patients with chronic pancreatitis, presenting with a dilated pancreatic duct.  
 Longitudinal pancreatico jejunostomy (LPJ) is safe. Many authors have reported 
low mortality rate (0 %) 10,11. Although longitudinal pancreaticojejunostomy has not been 
evaluated in controlled randomized trails, a technical review from the AGA on treatment 
of pain in chronic pancreatitis concluded ‘current consensus among surgeons is that 
drainage operations are safest and most likely to be effective’ 12. Some studies suggest 
that pain control achieved by pancreatic decompression is higher in nonalcoholic 
pancreatitis than in alcoholic patients 13. In contrast, another report failed to find any 
difference in the pain relief provided by lateral pancreaticojejunostomy between alcoholic 
and abstinent patients 14. 
 The main advantage of lateral pancreaticojejunostorny is the maintenance of 
pancreatic exocrine and endocrine function. In the past, the demonstration of a small but 
significant loss of pancreatic exocrine and endocrine function after pancreatic drainages 
procedures was mostly obtained from retrospective, nonstandardized studies 15. Two 
prospective, randomized studies have shown that successful pancreatic duct internal 
drainages may actually postpone the appearance of exocrine and endocrine 
insufficiency16, 17. The hypothesis that neural inflammation is an important pathologic 
mechanism of pain and the high incidence of ductal alteration and\or inflammatory mass 
in the head of pancreas motivated the concept of resection of inflammatory tissue as the 
treatment of choice of pain in chronic pancreatitis18. Pathological studies in combination 
with modern molecular biology investigations, suggest that the pancreatic head is the 
“pacemaker” of the diseases in most of patients with chronic pancreatitis 19. However the 
triggering mechanisms for pancreatic enlargement are still not known, in particular it is 
unclear what trigger growth factors to step into action. 
 RESECTIONAL PROCEDURES: 
 
 For the past 15 years pancreaticoduodenectomy has been the procedure of choice 
in many institutions for treating patients with chronic pancreatitis presenting with 
pancreatic head complications. Twenty years ago, the reported operative mortality for 
pancreaticoduodenectomy was unacceptable high in many centres (about 20%). With 
increasing experience with proximal pancreatectomy for cancer, operative mortality has 
progressively decreased so that nowadays most centres that treat large numbers of 
patients have an operative mortality well below 5%. Indeed, operative mortality of less 
than 2% is reported with increasing frequency in series of more than 50 patients20, 21. 
Although postoperative morbidity approaches 40-50%, complications are largely 
manageable and reversible. A positive loop has developed in which the reduction in 
mortality and morbidity has led to wider applications of proximal pancreatectomy, which 
in turn increases surgical experience and further improves results22. 
Pancreaticoduodenectomy for chronic pancreatitis also has an obligate potential long-
term morbidity. In patients with a normal pancreas, PD has no important clinical effect on 
endocrine or exocrine reserve. However, in the context of chronic pancreatitis, pancreatic 
endocrine and exocrine insufficiency often develops in the absence of any surgical 
resection as the natural course of the diseases. Because proximal pancreatectomy 
removes about 40% to 60% of the pancreatic parenchyma, the possibility of prematurely 
precipitating postoperative pancreatic insufficiency must be considered when such an 
approach is contemplated. Although exocrine insufficiency had developed in an 
additional 26% of patients at follow-up and endocrine insufficiency in an additional 30%, 
the mean time to onset of diabetes mellitus was 4.7 years postoperatively. While this 
suggests that the chronic fibrosis and glandular destruction of chronic pancreatitis 
progressed in the pancreatic remnant, the proximal parenchymal resection possibly 
contributed to a more premature loss of pancreatic endocrine and exocrine reserve and 
disruption of enteroinsular axis. Similar long-term sequelae of the combination of chronic 
pancreatitis and proximal pancreatectomy have been well described previously  23.   
 Distal pancreatectomy is a safe procedure (perioperative mortality 0-3.8%, 
morbidity 15-31%) that may be performed with or without splenectomy 24, 25. It provides 
long-term pain relief less reliably than PPPD or Classical PD unless the pancreatic 
inflammatory process is specifically localized to the body or tail of the gland (eg. 
obstructive pancreatitis secondary to a ductal stricture). Even in patients with such focal 
distal disease, pain relief with distal pancreatectomy has been inconsistent 25, 26, 27.  
Rattner et al. reported good pain relief in only 31% of patients undergoing distal 
pancreatectomy for distal chronic pancreatitis uncomplicated by a pseudocyst 26.  Sawyer 
and Frey, on the other hand, found adequate pain relief in 90% of those with distal 
disease at a mean follow-up of 4 years 27. They emphasized that distal pancreatectomy for 
chronic pancreatitis should be utilized only in appropriate patients (duct < 5 mm 
diameter, disease seen on CT and ERCP to be restricted to the pancreatic body, tail or 
both), a population comprising 5-15% of patients with chronic pancreatitis 27. In a more 
recent review of 40 patients with a single, prominent stricture of the main pancreatic duct 
and chronic pancreatitis in the obstructed segment, Sakorafas et al. found that distal 
pancreatectomy produced significant pain relief in 81% of patients at a mean 6.7 years of 
follow-up 25. Eventually, 45% and 47% of these patients developed postoperative 
endocrine and exocrine insufficiency, respectively 25. 
 Distal left to right sided resections (60-90% distal pancreatectomies) and total 
pancreatectomies present considerable morbidity and mortality rates related to the 
metabolic consequences of massive resection 28. Induction of endocrine and exocrine 
insufficiency even after distal pancreatectomy leads to multiple problems with nutritional 
management. 
  
COMBINED RESECTION AND DRAINAGE PROCEDURES: 
   
 The association of pancreatic head resection with a longitudinal 
pancreaticojejunostomy, combining with advantages of maximization of ductal 
decompression provided by the drainage procedure and the efficacy of cephalic 
pancreatic resection in pain control, has been used with  good results.  Beger et al were 
the pioneers of the duodenum-preserving pancreatic head resection. The innovative 
subtotal head resection involves an anatomic resection of part of the head and uncinate 
process beginning just to left of intrapancreatic portion of common bile duct and 
extending to the neck of the gland. This leaves a minute portion of pancreatic tissue along 
the medial wall of the duodenum and all the body and tail of the gland. Internal drainage 
is restored by two pancreaticojejunostomies, one to the body/tail region, with addition of 
a longitudinal pancreaticojejunostomy if necessary, and a separate anastomosis to the 
paraduodenal pancreatic remnant. The rationale of this procedure is to remove only part 
of the diseased pancreatic head, preserving the extrapancreatic organs including the 
duodenum with its role in regulation of glucose metabolism.  
  The most commonly used modification of the duodenum-preserving pancreatic 
head resection was originally proposed by Frey and Smith in 1987 in which a core of 
pancreatic head is resected nonanatomically, leaving a rim of pancreatic tissue adjacent to 
the portal and mesenteric veins. This limited resection of the head of the pancreas is 
technically easier to perform than the Beger operation because it does not necessitate 
transaction of the gland above the portal vein and thereby minimizes the risk of a 
bleeding complication, especially in the presence of extrahepatic portal hypertension. In 
chronic pancreatitis, the crucial triangle lies between the distal common bile duct, the 
wirsunigian duct and the superior mesenteric-portal vein. This region is addressed by 
classical resection of PD, by PPPD, by DPRHP and by Frey procedure.  
  The overall results of these DPRHP and LRLPJ show long-term relief in 75-95% 
of patients 29, 30. Two prospective, randomized studies conducted by the same group in 
two different periods, compared the DPRHP and LRLPJ. In both trials, the two 
procedures were equally effective concerning pain relief, preserving of pancreatic 
function and quality of life 31, 32.  The postoperative morbidity, however, was 
significantly lower with LRLPJ. Two other prospective, randomized trials comparing the 
DPRHP either to PPPD or to the classical PD 5, 33 showed that pancreatic exocrine and 
endocrine function was preserved by the Beger procedure, which was also superior to PD 
regarding long-term pain relief in one trial 5 
  Avoiding late postoperative complications must be a matter of concern in 
surgical treatment of chronic pancreatitis. Considering the most imperative issue of 
sustained quality of life improvement, the different variations of duodenum-preserving 
pancreatic head resections proved superior in comparison to PD, including the pylorus-
preserving modality. The excellent results obtained with these methods underlie that 
organ-sparing techniques should be preferred in the surgical treatment of chronic 
pancreatitis. 
 There are several reasons why duct decompression might fail to control pain in 
patients with chronic pancreatitis, as detailed in a report by Markowitz et al 34. These 
include pancreaticojejunostomy anastomosis that is inadequate or stricture. Strictures 
may also affect the intrapancreatic segment of the common bile duct and the duodenum, 
and are particularly likely to do so in the large duct form of chronic pancreatitis. 
Recurrent or persisting acute inflammation in the gland can produce pain, pseudocyst or 
even abscess. Pancreatic cancer was unsuspected but present in two of the patients in our 
series. Markowitz reported 13% of unrecognized pancreatic cancer in their series 34.  
 Early failures, may have been because the wrong operative strategy was chosen 
initially. Late failures may have been the result of disease progression, neuritis or other 
factors. Continued ethanol consumption has been associated with the greater likelihood of 
continuing or increasing pain 35.  
 Strategies for remedy of pain are dependent of the investigative workup. 
Redrainage of the pancreatic duct, limited resection of distal undrained segments and 
biliary decompression can benefit selected patients. The options for those patients are 
limited. Because of the anatomic evidence for a sensory neuropathy in the head of 
pancreas in chronic pancreatitis 36 and because a Whipple-type or duodenum-sparing 
resection of the pancreatic head have been reasonably successful as primary surgical 
therapy for chronic pancreatitis, Markowitz et al have employed pancreatic head 
resection in an attempt to salvage a poor outcome after pancreaticojejunostomy in a 73% 
of patients (11 patients of 15). They obtained 40% pain-relief and 30% partial relief in 
addition. Two patients were subjected for completion pancreatectomy 34. Whole pancreas 
and islet cells transplantation 37 are under investigations as alternative adjuncts to this 
problem. 
 
ALCOHOL ABSTINENCE: 
 
Most 35, 38 but not all 6, retrospective studies suggested that alcohol abstinence leads to reduction of pain in individuals 
with chronic pancreatitis. There have been no prospective studies performed, however, to ascertain directly the results of alcohol 
abstinence on reduction of pain in these patients. Strum 38  reported the clinical experience regarding abstinence and long-term 
outcome in patients with alcoholic chronic pancreatitis. Forty-two patients had an average 5.4 years of follow-up. Disability or death 
occurred in all patients who continued to drink heavily as compared with 38% of those who abstained or diminished their intake. A 
pooled analysis was also performed, including seven case series, comprising over 450 patients. Abdominal pain was significantly less 
common in those who stopped alcohol intake. Lankisch et al did not find a significant difference in pain relief between patients with 
alcohol-induced chronic pancreatitis who stopped drinking and those who did not 6. There is also some evidence that patients who 
continue to drink are more likely to develop pancreatic complications 39. Brinton et al 40  reported results of lateral 
pancreaticojejunostomy in 39 patients with chronic pancreatitis and found no correlation between the pain relief in alcoholic chronic 
pancreatitis and those who were not alcoholic . This is in contrast to report by Sato et al, who found that over mean period of 9.1 years 
only 50% of patients with alcoholic pancreatitis had a good result after surgery compared to 83% of those who had nonalcoholic 
pancreatitis 41. Another report by Sharma et al 42 found that 88% of patients of patients with nonalcoholic chronic pancreatitis had 
immediate and lasting pain relief.  
In the only major report on the results of surgery in 33 patients with nonalcoholic chronic calcific pancreatitis from South 
India, 77% of 26 surviving patients had good relief of pain at a median follow-up of 28 months 43. 
 
ENDOCRINE AND EXOCRINE INSUFFICIENCY: 
 
Diabetes occurs in 85% of patients with chronic pancreatitis over a 25-years period. Nearly 50% of these patients need 
insulin therapy.  In a 3-yrs. study on 70 patients with tropical calcific pancreatitis, (75 % had pain, 52% diabetes, 28 % weight loss, 2 
% steatorrhea).  22 patients underwent LPJ 44 , most insulin requiring diabetic patients achieved a reduction in insulin dosage or could 
stop insulin altogether.  In an another study  45  LPJ was performed in 10 patients with tropical chronic pancreatitis (diabetes in all, 
pain in 6, steatorrhea in 6).  At 1-year follow-up, abdominal pain was relieved with patients experiencing weight gain, improved 
working capacity and quality of life.  Their mean weight increased from 34 to 38.3 kg. Of 6 patients with steatorrhea, three were fully 
relieved, 3 had partial relief and, one still had steatorrhea and yet had gained 11 kg of body weight over 1-1/2 yr.  The mean insulin 
requirement fell from 46 U to 34 U per day. Nealon et al 46 reported that in patients with mild moderate chronic pancreatitis, 
operative decompression of pancreatic duct early in the course of the disease did not improve but halted the progressive loss of 
endocrine and exocrine functions.  Prospective evaluation in 87 patients, who underwent decompression of duct to relieve abdominal 
pain, was reported.  Among them, 17 patients were readmitted to operative or nonoperative treatment. Nine of these randomized 
patients were operated upon and eight were not.  Seven of nine (78 %) patients retained their functional status in follow-up, whereas 
only two of eight patients (25%) randomized to nonoperation preserved their functional status.  These authors supported the concept 
that high intra – ductal pressure may contribute to the ongoing loss of function and perhaps to an ongoing level of subacute 
inflammation, which restricts utilization of nutritional substrates. 
Hammel et al 47  who, over a follow-up period of 15 year found that the prevalence of diabetes was 21% in 222 patients 
who had undergone surgery, in contrast to 33% in 224 patients managed conservatively.  Similar findings were reported 48 after Extra 
corporeal Shock wave Lithotripsy (ESWL) of pancreatic stones when 23 (77%) out of 30 patients with steatorrhea improved, as did 
two of five patients with abnormal glucose tolerance. 
In another study, Brand et al 49  reported pain relief in 81.6%, an improved quality of life in 68.4% and weight gain in 
68.2% (with prior weight loss) of patients after endoscopic drainage of the pancreatic duct with ESWL of pancreatic stones in 48 
patients with chronic calcific pancreatitis over a period of 1 year. Pancreatic steatorrhea improved in 10/13 (67.9%) patients, and 
normalization of endocrine pancreatic function occurred in five patients (p = 0.45); median glycosylated hemoglobin (Hb A1C) levels 
decreased significantly after pancreatic ductal drainage. 
In an Indian study involving 53 patients with tropical chronic pancreatitis who underwent modified Puestow procedure, 
prospective comparison was done between 46 operated patients who completed 5 year of follow up with 40 patient who did not 
undergo operation 50 41/46 operated patients ( 89%) had complete pain relief, whereas in those  managed conservatively, even though 
they had milder symptoms, Pain relief occurred  in only 58%.  In the operated group, the mean fasting (209 mg%) and postprandial  
(320 mg%) blood glucose and insulin requirements  (40 units/day) decreased postoperatively (fasting 162 mg%, Postprandial 254%. 
Insulin requirement 18.2 units/day; p < 0.01), and steatorrhea improved in one of six patients.  In the nonoperated group, endocrine 
and exocrine pancreatic function remained unchanged. Authors have shown that patients with tropical pancreatitis who undergo the 
modified Puestow’s procedure not only have relief from pain but also improvement of diabetes.                  
In an another Indian prospective study of pancreatic β cell and exocrine function following duct decompression in tropical 
calcific pancreatitis by E. Bhatia et al 51  , reported that although there was a significant improvement in the pain score with a 
complete remission of pain in > 90% of patients, there was no change in β- cell function and exocrine function after 1 year of follow-
up. 
 In alcoholic chronic pancreatitis, the results of decompression surgery have been inconsistent with regard to improvement 
in endocrine and exocrine functions. Adams et al 11 in a retrospective study of 85 patients with alcoholic chronic pancreatitis, showed 
that insulin use continued in 23% and that taking of pancreatic enzyme supplements persisted in 34% after the modified Puestow’s 
procedure.  The author suggested that pancreatic exocrine and endocrine functions worsened after drainage surgery. 
In Amman’s study 8  drainage surgery did not delay the development of exocrine or endocrine insufficiency in chronic 
alcoholic pancreatitis patients.  The inconsistency of results in alcoholic chronic pancreatitis may reflect the difference in the extent of 
pancreatic damage at the time of surgery and whether or not the patient has stopped drinking. 
Ramesh and Augustine 52  reported that glucose tolerance improved in only 18% of their TCP patients, while Sharma et al 
13 noted that these was no significant change in insulin requirement after intervention. 
The two most striking changes in tropical calcification pancreatitis are marked atrophy of exocrine pancreas but more 
involving the islets of Langerhans  instead the latter  shown on consistent hypertrophy and hyperplasia. Further there is an unequivocal 
evidence of nesidioblastosis in tropical chronic pancreatitis. 
 Nesidioblastosis is a multifocal, ductuloinsular proliferation involving all cellular components of the islets and is usually 
seen in hyperinsulinemic hypoglycemia of childhood. Histochemical staining using immunoperoxidase has shown a strong activity for 
insulin in both existing and newly formed islets. Histochemical evidence thus suggests continued insulin production.  The insulin 
changes in tropical chronic pancreatitis are therefore paradoxical. Despite insulin hyperplasia and hypertrophy, the patient suffers from 
a resistant form of diabetes mellitus. The role of islets in the etiopathogenesis of the brittle, but insulin-dependent diabetes is very 
intriguing. One mechanism may be failure of release of insulin from islets.  The other may be presence of circulating antibodies, 
resulting in brittle diabetes with requirement of very high doses of insulin and frequent episodes of hypoglycemia. 
The most striking findings in alcoholic chronic pancreatitis, on the other hand are ductal dilatation with protein plugs, fat 
necrosis, parenchymal necrosis, acute inflammatory reaction, and parenchymal calcification 50. The ductoinsular changes such as islet 
hypotrophy/ hyperplasia and nesidioblastosis, characteristically seen in tropical chronic pancreatitis, as mentioned earlier are rarely 
seen in alcoholic pancreatitis. This difference is pathology may explain the variable changes in pancreatic dysfunction after drainage 
surgery in alcoholic chronic pancreatitis as opposed to that in tropical chronic pancreatitis. 
The possible explanation for the improvement in endocrine function after decompressive surgery in tropical chronic 
pancreatitis may lie in the fact that in this disease, the islet cells may be normal or even increased in number 50 , in fact the K value 
(the slope of disappearance of glucose from the blood after intravenous injection) may be normal in patients with tropical chronic 
pancreatitis who have overt pancreatic diabetes.  It is postulated that obstruction of the pancreatic duct, together with the dense 
intralobular and perilobular fibrosis, creates a compartment syndrome and that the insulin deficiency results from poor islet perfusion 
syndrome and the poor insulin absorption due to raised interstitial pressures. There is experimental evidence 53 to prove that ductal 
decompression and surgical incision of the gland improve the blood flow to the pancreas and lower the increased interstitial and 
perfusion pressures.  The improvement of pancreatic ischemia may be associated with relief of pain, and the enhanced perfusion of the 
islet of Langerhans may increase insulin transfer and absorption, thereby resulting in an improvement of the disease. 
The principal criterion to determine candidacy for ductal drainage in Nealon’s series was the presence of a dilated 
pancreatic duct. Thus, what the study actually reports is the outcome of pancreatic drainage in patients with dilated ducts versus the 
natural history of patients with chronic pancreatitis and no ductal dilatation.  It is therefore uncertain whether the slow deterioration of 
pancreatic endocrine function in patients who underwent surgery is actually caused by surgical drainage procedures.  
 Distal pancreatectomy was associated with increased risk of diabetes mellitus 
which has been suggested by several reports 25 . However, most of these studies followed 
up small number of patients only, often for a short time and did not compare distal 
pancreatectomy with other elective pancreatic surgical procedures, or lacked a control 
group. In a review of seven studies including a total of 100 patients with chronic 
pancreatitis followed up for 3.6 to 7.0 years after a 40 to 80% distal pancreatectomy have 
shown that the prevalence of IDDM increased from 0 to 10% preoperatively to 19%-48% 
in the late postoperative period 53 . Increasing the extent of distal pancreatectomy to 80 to 
95% led to a postoperative rate of diabetes mellitus of 58% to 100% and increased late 
mortality 25,26 . 
The influence of pancreaticoduodenectomy on the risks of postoperative diabetes mellitus is unclear 54, 55. It has been 
shown that pancreaticoduodenectomy results in decreased insulin secretion after surgery 56. In a review of eight series including a 
total of 325 patients with chronic pancreatitis followed up between 25 months and 6.2 years after pancreaticoduodenectomy found an 
increase in the rate of IDDM from 0% to 16% preoperatively to 11% to 68% in the late postoperative follow-up 53. 
   Following conventional pancreaticoduodenectomy or PPPD, patients showed about a 20% decrease in the PABA test or 
decreased faecal chymotrypsin 57. In this group, insufficient weight gain despite intake of regular amounts of pancreatin was shown to 
be associated with decreased pancreatic exocrine function postoperatively 58 .   
 In patients with preexisting chronic pancreatitis, the percentage of patients with steatorrhoea was increased from 3.7% to 
19% by 40- 80% distal resection, from 9.0% to 37.6% by 80-95% distal resection and from 5.2 to 55% by Whipple procedure. The 
average faecal loss of fat following a 80-95% distal resection in patients ingesting 100g fat per day was 26.4 g/day ( normal: less than 
5-7 g/d), that is, the coefficient of fat absorption in these patients was reduced to 73.6% compared with greater than 93-95% in healthy 
humans 59. Residual lipid digestion in spite of almost complete loss of pancreatic exocrine tissue is probably due to gastric lipase. 
 
ASSOCIATED COMPLICATIONS: 
 
  Pseudo cysts complicate chronic pancreatitis in 20-40% of patients and unlike 
those secondary to acute pancreatitis, tend to persist and cause further complication 61. In 
a report from Nealon et al 60, duct drainage alone in a chronic pancreatitis (dilated duct), 
patients with pseudo cyst is sufficient and effective in completely resolving associated 
pseudocysts. They have shown that dynamics of the ductal system completely determine 
the course of pseudocysts in patients with chronic pancreatitis. They placed intra 
operative external drains in the pseudocysts of 33 patients who had LPJ alone, and the 
output of these drains was essentially zero immediately after operation. The fact that 
external drain outputs dropped so promptly further illustrates the dominant role that 
ductal pressure play in pseudocyst dynamics.  
    There are reports of conservative treatment of pancreatic pseudocysts 61,62, but 
the majority of pseudo cysts, especially when symptomatic, require surgical or 
interventional approach 63 . The major modalities of therapy include endoscopic or 
percutaneous drainage and surgery for internal drainage or resection. ERCP use can 
predict treatment success and, in our study, rendered a protective mortality effect 64.  
Accumulating evidence suggests that more emphasis should be given to ductal anatomy 
than cyst characteristics. Studies have confirmed that main pancreatic duct complete 
obstruction is a poor prognostic factor of percutaneous drainage 64,65.   The benefit of 
ERCP may be both diagnostic and therapeutic given the ability to endoscopically stent 
the main pancreatic duct. Caution should be exercised in stenting chronic pancreatitis 
given the strong potential for numerous stent exchanges over the long course of the 
disease. ERCP use likely should be increased given its benefit and low use, as shown by 
others 64, 66 .  Increased use of ERCP should be tempered by the potential adverse events 
associated with ERCP use, particularly at an institutional or a provider level. In addition, 
the advent of MRCP may address of the pancreatic duct while avoiding some of the 
adverse events associated with ERCP. Endoscopic therapy, although successful in some 
series 67 , has limitations and external drainage often leads to a persistent pancreatic 
fistulae. Last, surgical drainage of pseudocyst is safe, effective, and enduring 64,66. Clear 
indications for surgical drainage remain large or multiple cysts; cysts with adjacent organ 
involvement, particularly splenic involvement; biliary pancreatitis and chronic 
pancreatitis. 
  Surgical internal drainage can be preformed either to the stomach or to a jejunal 
limb. In patients with pseudocysts and main duct dilatation, internal drainage of the cyst 
must be associated to a longitudinal pancreaticojejunostomy. The good results obtained 
with this technique stress the importance of providing an outflow route for the obstructed 
pancreatic duct, and not just for the pseudocyst. Pancreatic pseudocysts complicated by 
splenic parenchymal involvement respond poorly to percutaneous drainage and are 
preferably treated by distal pancreatectomy and splenectomy.  Considering the diversity 
of their presentations, the management of pseudocysts should be tailored to meet each 
patient’s individual needs. As there have been no prospective, randomized trails 
comparing head to head result of the three available forms of therapy further studies are 
needed before percutaneous drainage or endoscopic approach can be definitely 
recommended as the preferred initial mode of pseudocyst management.  Potentially, 
percutaneous drainage could be used as a “bridge“procedure for patients who have an 
infected pseudocyst, are malnourished, or are poor surgical risk. Clear end points for 
failure of percutaneous drainage are necessary.  Endoscopic drainage may have specific 
clinical application in pseudocysts in the head of the pancreas or small persistent 
pseudocysts. 
  In a review, terminal biliary stenosis  complication reportedly occurs in 3 % to 23 
% of patients with chronic pancreatitis 68. Preoperative diagnosis was based on history of 
jaundice, marked elevation of alkaline phosphatase, or both and visualization of the 
lesion on endoscopic retrograde studies.  Failure to identify and correct this complication 
may result in continued disability including pain, recurrent cholangitis, and ultimately 
biliary cirrhosis.    
 Determining whether biliary obstruction is due to chronic pancreatitis or 
malignancy can be a very challenging clinical problem. This differentiation is of utmost 
importance since malignancy will require resection whereas a biliary drainage procedure 
would suffice for benign disease. Wapnick and associates have defines a number of 
parameters, which make a diagnosis of inflammatory disease of the pancreas more likely 
than cancer 69 . In their study, patients with chronic pancreatitis were significantly 
younger than patients with carcinoma, having an average age of 47 versus 62. Total 
serum bilirubin was much higher with pancreatic malignancy being 18.5 mg/dl compared 
with 5.6 mg/dl in chronic pancreatitis. Perhaps more important than the absolute rise of 
bilirubin was the pattern of elevation. In patients with malignancy, bilirubin rose 
progressively until the biliary tree was decompressed, while with chronic pancreatitis, 
bilirubin rose to an apex and then fell as the attack resolved. In other words, jaundice 
usually waxes and wanes in chronic pancreatitis while in cancer it increases relentlessly 
69.  All patients with pancreatitis in their study had an admission bilirubin that fell below 
5 mg/dl within two weeks; in all patients with malignancy the level continued to rise. 
They concluded that the course of the bilirubin during the first seven to ten days of 
hospitalization was the single most accurate test distinguishing carcinoma from 
pancreatitis. Likewise, Frey and coworkers found that serum bilirubin was seldom higher 
than 10 mg/dl in chronic pancreatitis and usually diminished within 7-10 days as the 
inflammatory exacerbation subsides 70. Clinically, patients with carcinoma usually have a 
brief antecedent history of abdominal discomfort with an unremitting elevation of 
bilirubin. Patients with chronic pancreatitis have symptoms of recurrent upper abdominal 
and back pain that has been present for some time prior to the development of jaundice. 
Radiological studies can suggest malignancy but are not absolutely diagnostic. A fixed 
high-grade, short stenosis or complete obstruction of intrapancreatic bile duct most often 
suggests carcinoma the head of the pancreas, distal bile duct or ampulla of Vater. In 
pancreatic carcinoma, a “shelf” from the tumour is usually seen with cholangiography. 
The gradual tapering of the intrahepatic duct in chronic pancreatitis should distinguish it 
from the abrupt, short obstruction seen in pancreatic cancer. However, exceptions to this 
rule are sufficiently frequent to render cholangiographic findings unreliable in 
distinguishing these two disease processes.   
 Both pancreatic cancer and chronic pancreatitis rarely appear as duodenal 
obstruction without causing jaundice.  Patients with carcinoma of the pancreas who have 
duodenal obstruction without jaundice are usually found to have widespread metastatic 
disease at the time of surgical exploration.  An irregular stenotic lesion in the duodenal 
sweep is highly suggestive of malignancy, particularly when associated with obstructive 
jaundice. Radiologically, the appearance of pancreatic malignancy is that of a 
circumferential constriction suggesting mucosal invasion, or fixed, distorted folds with 
nodularity, and speculation . Endoscopically, reactive duodenal changes including 
marked mucosal friability and nodularity are seen with both conditions.  In summary, no 
single clinical, biochemical, or radiological feature reliably differentiates a biliary 
stricture or duodenal obstruction secondary to chronic pancreatitis from one due to 
pancreatic cancer, A high degree of clinical suspicion is needed to be certain one is not 
missing a pancreatic cancer.  
 The alternative choices for the management of biliary stricture this complication 
are Choledochoduodenostomy and Choledochojejunostomy. Cholecystojejunostomy may 
be the only surgical option for surgical biliary decompression in jaundiced patients with 
portal thrombosis secondary to chronic pancreatitis. Biliary endoscopic sterling provides 
acceptable short and medium term resolution of common bile duct obstruction, but it can 
not be recommended as definitive therapy due to less acceptable long term results that are 
inferior to surgical treatment 71.  In one study, the presence of pancreatic head 
calcifications proved to be the main deterrent to success of endoscopic stenting 72.  
Endoscopic stent, however, may be indicated or at least tried first in the presence of 
jaundice associated with cavernomatous transformation of the portal vein.                 
   Internal pancreatic fistulas characterized by pancreatic ascites and\or pleural effusion secondary to leaking pseudocysts 
or disruption of the main pancreatic duct not properly walled off by inflammatory reaction, are well recognized complication of 
chronic pancreatitis 73,74,75. The diagnosis of internal pancreatic fistulas needs a high index of suspicion. The amylase levels will 
always be markedly elevated (>1000 Somogyi units/ 100 ml) and in the absence of hypoalbuminemia the albumin level will be > 3 g/ 
100 ml. The serum amylase level of patients with internal pancreatic fistulas is not always raised. Endoscopic retrograde 
cholangiopancreatography has been considered to be the modality of choice in depicting the anatomy of the pancreatic ductal system 
and the internal pancreatic fistula site, and in the possible demonstration of fistulas tract and provides the road map to pancreatic duct, 
which is vital for the surgeon in deciding the appropriate surgical procedure. Therapeutic success of treatment of internal pancreatic 
fistulas may be achieved in 50-80% of patients with mild or moderate chronic pancreatitis after initial nonoperative management, but 
medical management should not exceed beyond 2-3 weeks 74. Patients with advanced disease have a much lower success rate of 
medical treatment and should be considered for early surgical intervention 73, 74.The surgical treatment of internal pancreatic fistulae 
will depend on the nature of the lesion demonstrated by direct ductal imaging by ERCP or by MRCP. Patients with a leaking 
pseudocysts or a disrupted dilated pancreatic duct will be best treated, respectively, by a cyst or a pancreatic duct internal drainage 
procedure, whereas distal pancreatectomy should be indicated for these patients with a narrow disrupted duct. External pancreatic 
drainage, avoiding loss of exocrine pancreatic function, may be a good alternative to resection in selected patients, but may be 
complicated by a persistent pancreaticocutaneous fistula in patients with proximal pancreatic duct obstruction 73 . More recently 
transpapillary pancreatic ductal stents have been used in patients who failed to respond to conservative measures 75. Desirable 
prospective, randomized studies, comparing endoscopic and surgical management of internal pancreatic fistulae will certainly be 
difficult to conduct considering the diversity of ductal lesions present in this situation that makes patients difficult to compare. 
The relevance of segmental portal hypertension for a patient with chronic pancreatitis is still poorly understood 76. Only 
transaction of the pancreas as in duodenum-preserving pancreatic head resection or proximal pancreatectomy will truly free the portal 
vein and superior mesenteric vein immediately. The removal of the majority of the inflammatory tissue around these vessels and a 
postulated regression of inflammation might also improve blood flow. However, complications from segmental portal hypertension 
are extremely rare. Its presence should therefore not influence the choice of an operation. In contrast complete portal vein obstruction 
with cavernomatous transformation was considered as contraindication for any effective surgical procedure for chronic pancreatitis. 
The risk of hepatic ischemia was considered too high to perform a partial pancreaticoduodenectomy. Extended drainage and limited 
resection procedures, in contrast, were shown to deliver control of symptoms and be safe at the same time 77.                              
 
 
RISK OF CONCOMITANT PANCREATIC CANCER: 
 
 
 The association of concomitant pancreatic cancer of the time of surgery of chronic pancreatitis is well known. The surgeon 
should bear this in mind both during initial evaluation of the patient with chronic pancreatitis as well as intraoperatively and  
subsequent evaluation for recurrence of pain, jaundice or weight loss should also bring suspicion of malignancy.  Patients with chronic 
pancreatitis have an increased risk of developing pancreatic adenocarcinoma in relation to the general population. Two cohort studies 
demonstrate a strong correlation between chronic pancreatitis and an eventual diagnosis of pancreatic cancer, the cumulative risk of 
pancreatic cancer varying from 2.3 to 26.7% 78,79. In a multicenter historical cohort study of 2015 subjects with chronic pancreatitis, 
who were recruited from clinical centres in 6 countries, a total of 56 pancreatic cancers were identified during a mean follow-up time 
of 7.4 ± 6.2 years. The expected number of cancer cases calculated from country specific incidence data and adjusted for age and sex 
was 2.1, yielding a standardized incidence ratio of 26.3 (95% confidence interval, 19.9-34.2). For patients with a minimum of 2 or 5 
years of follow-up, the respective standardized incidence ratios were 16.5 and 14.4. The cumulative risk of pancreatic cancer in 
subjects who were followed-up for atleast 2 years increased steadily, and 10 and 20 years after the diagnosis of pancreatitis, it was 1.8 
and 4.0, respectively. Lowenfels et al concluded that the risk of pancreatic cancer is significantly higher in subjects with chronic 
pancreatitis and appears to be independent of sex, country and type of pancreatitis 78. 
  In patients with hereditary pancreatitis the estimated cumulative risk of pancreatic cancer approaches 40% and reaches 
almost 75% for patients with a paternal inheritance pattern 80. 
 Patients with tropical pancreatitis who develop pancreatic cancer differ from those in whom cancer occurs de novo in the 
presence of extensive calculi, higher frequency of diabetes mellitus, and presentation with abdominal pain rather than jaundice. Unlike 
de novo cancer, which has a predilection for the pancreatic head, Tropical pancreatitis cancer occur more frequently in the body and 
tail. About 60% of tumours appear to arise from an area in the body of the pancreas close to the neck. Once carcinoma supervenes, 
survival is short (median 11 months) despite resection of the tumour and chemotherapy 81.  
  Preoperative identification of cancer may be difficult in many cases. The occurrence of weight loss, appearance of constant 
upper abdominal pain, and deterioration in diabetic control should raise a suspicion of malignancy. Intraoperatively, the differential 
diagnosis may represent a formidable task considering the hardness of the enlarged pancreas present in both situations, which makes 
distinction by surgical palpation ineffective. Even in experienced centres approximately 10% of patients harbor a pancreatic 
carcinoma that is only diagnosed by histologic proof at the time of resection or after failure of drainage 29,34. In some reports, fine 
needle aspiration cytology proved to be of value for the diagnosis of pancreatic cancer 82, however only pancreatic resection or 
limited resection combined with external drainage can offer sufficient tissue material to accurately exclude malignancy 29,30,31. 
Needle and cytological biopsy specimens give false negative results in 20-30% and so are unreliable if they fail to show malignancy. 
In a report from Manheim surgical clinic, suspicion of cancer was the indication in 16.5% of patients operated upon for chronic 
pancreatitis 83.  The increased incidence of pancreatic cancer in patients with chronic pancreatitis 78 further emphasizes this dilemma 
and accounts for some of the increases in proximal pancreatectomy for chronic pancreatitis. 
 Therefore, when there is strong suspicion of an underlying malignancy, pancreaticoduodenectomy should be considered in 
surgically fit patients. The risk of tumour spillage that may occur during the resective stage of the Frey or Beger procedures represents 
a drawback of these techniques and outweighs the potential benefits of a duodenum preserving resection for these patients. 
 Patients with Intraductal papillary mucinous tumours of the pancreas (IPMT) may present with symptoms similar to these 
of chronic pancreatitis. It is thus important to rule out the presence of an IPMT in patients referred for surgical treatment of chronic 
pancreatitis, particularly in lesions located in head of the pancreas. Endoscopic ultrasonography may be useful tool in these 
circumstances. 
 
ENDOSCOPIC STENTING: 
 
First it is important to realize that the natural history of pain confounds response to therapy. In Ammann’s study 84, ~ 50% 
had intermittent pain and had a favorable course without surgery. If these patients had been submitted to a specific treatment 
(endoscopic, surgical, pancreatic enzymes, etc.), the favourable response would have been attributed to therapy. For example, there are 
two major endoscopic approaches: clearing stones from the pancreatic duct and/or stenting the pancreatic duct. Interestingly, by using 
the former approach, Cremer’s group 85 reported that the best results (longest pain-free intervals) occurred in the patients who had no 
pain or few attacks of pain before endoscopic therapy. By performing a multivariate analysis of their data, they found that the best 
predictor of a long pain-free interval was infrequent attacks of pain before therapy. This analysis led them to state that “the best results 
are obtained if endoscopic therapy is performed early:, it is “often effective for years”, and “propose endoscopic management early in 
the course of calcifying pancreatitis”. Instead, an equally plausible explanation of their results is that the patients who “responded” to 
therapy would not have had attacks of pain regardless of treatment.  
Similarly, these investigators interpreted results of their previous uncontrolled studies 86 that clearing of stones from the 
pancreatic produced pain relief in ~ 70% of patients. It is difficult to judge the effect of treatment in these studies because up to 71% 
of patients had relapsing pain and intervals between pain episodes varied from months to years. In addition, the frequency of painful 
attacks before treatment is not stated, the mean follow-up after treatment was short, and some patients had no or few attacks of pain. In 
another retrospective study, Smits et al, found that “endoscopic treatment of pancreatic stones is a valid approach in patients with 
pancreatic lithiasis” 87. However, they did not clear stones in 11 of the 53 patients and 3 of these 11 patients (27%) had complete 
symptom relief; only 4 of 11 (36%) needed surgery; and 23% had treatment related complications (bleeding, exacerbation of 
pancreatitis, peroration, pancreatic abscess, stent clogging). It is unlikely that stenting of the pancreatic duct would have resulted in a 
similar improvement as compared to surgery because pain reduction after stenting only occurs in 54% of patients  and may only be 
transient there is little change of pancreatic blood flow and the procedure results in parenchymal and permanent ductal changes in a 
number of patients. In a long-term prospective study, Adamek et al has shown that endoscopic pancreatic drainage and ESWL had no 
significant effect on pain and glandular insufficiency in patients with alcoholic chronic pancreatitis 88. 
It is important to recognize that unproven treatments may be associated with significant complications and are expensive. 
For example, stenting the pancreatic duct, another proposed endoscopic treatment for pain, has an overall success of 85%, but pain 
reduction occurs in only 54% of the patients 89 and leads to parenchymal changes in 32% and no change in 5% of the patients after a 
mean of 192 days and concluded that stenting of the pancreatic duct was an experimental procedure. Of note, Cremer 85 hospitalizes 
patients 14 ± 14 days after the initial treatment, a very large expense.  
A recent prospective, randomized trial comparing resection and drainage procedures with endoscopic stenting in a large 
number of patients with painful obstructive chronic pancreatitis demonstrated surgery to be more effective than endotherapy in long-
term pain control 90.  
 
NEURAL BLOCK: 
 
Chemical or surgical neurotomies of pancreatic sympathetic pain afferents have been suggested as an alternative to 
operations on the pancreatic parenchyma in the management of patients with intractable pain from ‘small-duct’ chronic pancreatitis. 
The long-term results of percutaneous or endoscopic celiac plexus blockade are far from encouraging, since no more than 50% of the 
patients even develop a significant short-lived pain relief 91.  A prospective, randomized study comparing the efficacy of EUS-guided 
versus CT-guided celiac plexus block failed to show any advantage of either approach 92. Bilateral thoracoscopic splanchnicectomy 
significantly decreased intensity of pain and improved quality of life 93.  However, long-term pain relief was not often achieved and 
pain recurred in approximately 50% of the patients. Favorable results of splanchnicectomy appear to be related to the response to 
differential epidural analgesia (DEA) as only patients with DEA-predicted sympathetic pain benefit from splanchnic neural ablation 
94. The overall efficacy of this procedure also appears to depend on the patients to whom it is applied. In one study that included only 
patients with nonalcoholic pancreatitis, those who have had prior surgical or endoscopic interventions had a poorer response in pain 
relief compared to patients without prior intervention 95. On the contrary, two other studies involving mostly patients with alcoholic 
pancreatitis, found no correlation between the success rate of splanchnicectomy and the incidence of prior interventions directed at 
pain control 96, 97. Although bilateral thoracoscopic splanchnicectomy is safe, involves a minimal access approach, and may provide 
improved quality of life in patients with small-duct pancreatitis, further studies are needed to identify clearly the appropriate 
candidates for this procedure 95. 
 
 
QUALITY OF LIFE AFTER SURGERY FOR CHRONIC PANCREATITIS:   
 
The EORTC-QLQ has now been applied in two prospective randomized trials comparing surgical techniques in patients 
with chronic pancreatitis, which stress the draining or the resectional aspects of treatment to varying degrees 29,32. Statistically 
significant changes in functional and symptom levels were observed. In both trials, the patients’ overall quality of life improved 
considerably.  Relief of symptoms, especially of pain, fatigue, and loss of body weight, accounted for improvement of physical status, 
working ability and emotional and social functioning 29,31,32. These changes correlated well with the results of the separately 
assessed pain score and increase of body weight. The visual analog scale, as one feature of the pain score, has been shown to be a 
highly valid and reliable tool for measuring pain intensity (Ref.23,77 of SCNA). The additional information on frequency of pain 
attacks, analgesic regimen, and sick leave backs up the results of the visual analog scale. In comparison with McGill’s pain 
questionnaire, the pain score had previously been tested in 19 patients suffering from pancreatic carcinoma, proving its validity and 
reliability.  
 
  
AIM OF THE STUDY 
 
The aim of the study was to analyse the long-term results of surgery for the patients who underwent surgery for chronic 
calcifying pancreatitis in a single institution during the 15 yrs period (January 1990 - December 2004) and followed up during two-
year period from July 2003 to August 2005.  
This is largely a prospective study that analyses the medium and long term outcome of surgery for chronic pancreatitis with 
particular emphasis on the quality of life for patients based on the mortality and morbidity rates associated with surgery, relief of 
symptoms, analgesic use, employment and long-term sequelae like exocrine and endocrine insufficiency of   pancreatic surgery. 
 
 
 
 
 
 
 
 
 
 
 
 
PATIENTS AND METHODS 
 
Between 1990 and 2004, 151 patients were operated for chronic calcific pancreatitis at our department of Surgical 
gastroenterology, Government Stanley Hospital, Chennai. All these patients underwent pancreatic drainage or some form of 
resectional procedures. Patients who have completed at least 6 months follow up included in the study. Patients who underwent 
pseudocysts drainage alone or bypass operations performed for bile or gastric drainage alone were excluded from this study. Sufficient 
information was available in 100 patients.  The mean age at surgery was 35.6 ± 12.8 (Range 12 to 65 yrs).  There were 70 Men 30 
women.  The diagnostic workup includes X- ray Abdomen erect, USG abdomen, ERCP and CT Abdomen. MRCP was done in 
selected cases. All of the cases of chronic pancreatitis were confirmed by histological examination. 
Follow-up data were collected by periodic visits, telephonic interviews and information from family doctors. The records 
of all patients underwent drainage or resections for chronic pancreatitis at our department were reviewed. Preoperative date were 
reviewed included cause of chronic pancreatitis, clinical variables (symptoms, diabetes, and exocrine insufficiency), and 
morphological variables. Patients’ characteristics of both alcoholic and tropical chronic pancreatitis were analyzed. Alcoholic chronic 
pancreatitis was defined as chronic pancreatitis associated with the consumption of greater than 50 units of alcohol per week for at 
least 5 years with no other etiological factor.  
Preoperative variables examined were indication for surgery, type of pancreatic drainage or resection, morbidity and the 
mortality. The principal indication for operation was chronic pain, intractable to medical management associated with dilatation of the 
main pancreatic duct. Patient outcome was assessed by review of hospital inpatient and out patient records and telephone interview. 
Patients were assessed in the out patient clinic at 1 month, 3 months, 6 months and 1 year and annually thereafter. Data were recorded 
in a preprinted standard sheet with particular reference to operative morbidity and 30 day mortality rates; degree of pain relief, 
frequency and type of analgesia used, exocrine and endocrine insufficiency, weight gain, employment status, use of pancreatic enzyme 
supplements, alcohol consumption, hospital readmission, need for late reinterventions, co-existent medical disease, late mortality & 
causes of late death and quality of life assessment. The mean follow-up period was 43.5 months. The median follow-up period was 30 
months.  
Complete pain control was defined as “ no need of analgesic drugs” Partial pain control was defined as “need for minor 
analgesics” and no pain control was defined as “need of narcotics or hospital admissions”.   Diabetes mellitus was defined using 
World Health Organization criteria. Exocrine insufficiency was assessed clinically by the presence of gross steatorrhea at times 
supplemented by pancreatic function tests. Categorical data were analyzed using Pearson’s Chi – Squared test or Yates corrected Chi – 
Squared test or Fischer’s exact test as appropriate and Odds ratio were given with  95% confidence interval.  Continuous data were 
analyzed using student t – test. 
 
 
 
 
 
 
 
RESULTS 
 
Complete follow up data were available in 100 patients. 31 patients had alcohol pancreatitis, 66 patients had tropical pancreatitis, 2 
patients had hereditary pancreatitis and one patient had pancreas divisum. 
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The median duration of symptoms before surgery was 34.66 months (range 1 month to 360 months). 
 In 80 patients (80 %) the principal indication for surgery was chronic intractable pain. Other indications were: bile duct 
stenosis in 6 patients (6%), haemorrhage in 5 patients (5%), pseudocyst in 4 patients (4%), suspicion of malignancy in two patients 
(2%) and pancreatic ascites in 3 patients (3%).  
 Among the cases listed above, gastrointestinal haemorrhage was caused by bleeding into a pseudocyst in 3 patients and 
one patient presented with haemoptysis and haematochezia. One patient presented with ruptured pseudocyst with gastrointestinal and 
intraperitoneal bleed. 
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Common associated  symptoms included jaundice in 6 patients (6%) and gross exocrine insufficiency 17 patients (17%). 54 
patients (54%) had  endocrine  insufficiency  before surgery including 34 patients (34%) who were dependent on Insulin.  16 patients      
(16%) were taking regular daily oral analgesics, 84 patients (84%) were dependent on injectable analgesics for pain relief. 93 patients 
(93%) of working age were unemployed at the time of surgery. 
On morphological analysis, 94 patients (94%) had main pancreatic dilatations, 98 patients (98%) had main pancreatic 
ductal calculi, 51 patients (51%) had parenchymal calcifications, 32 patients (32%) had parenchymal atrophy, 24 patients (24%) had 
inflammatory head mass and 10 patients (10%) had pseudocysts. Pseudocysts were single in all 10 patients.  The site was at the 
pancreatic head region in 7 patients, body in 2 patients and tail in one patient. Pancreatic ductal strictures were seen in 9 patients and 
were at multiple sites in 5 patients, body in 2 patients, body and tail in one patient and one patient had stricture at head region. 
Purulent fluid in pancreatic duct was present in six patients. Four of them were diabetics. MPD disruption was present in 
3% of patients. One patient had disruption in the tail region. Two patients had disruptions in body of pancreas. Bile duct stenosis was 
present in 6 patients.  All of them had smooth tapering terminal bile duct strictures. 
Pancreatic abscess were seen four patients. Two patients had abscess in tail and body region. One patient had abscess in the 
body region and one had abscess in the tail region. One patient had mass in the neck region. One patient had associated necrosis of 
peripancreatic region around head. One patient had pancreas divisum, which was responsible for recurrent pancreatitis.  
.Morphological findings are summarized in Table No. 1.     
 
 
 
 
 
 
 
 
 
 
 
 
 
Table.No.1 The morphological characteristics in 100 patients: 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Findings Percentage
 
MPD dilatations 
 
MPD ductal calculi 
Parenchymal calcifications 
Parenchymal Atrophy 
Inflammatory Head Mass 
Pseudocysts 
Ductal strictures 
   Multiple          (n=5) 
   Body               (n=2) 
   Head                (n=1) 
   Body & Tail    (n=1) 
Bile duct stenosis 
Purulent fluid in MPD 
MPD disruptions 
Pancreas abscess 
       Tail & Body 
       Body 
      Tail   
Mass Tail & Body 
Mass Neck  
Necrosis 
Pancreas divisum 
 
94% 
 
98% 
51% 
32% 
24% 
10% 
9% 
 
 
 
 
6% 
6% 
3% 
4% 
2% 
1% 
1% 
2% 
1% 
1% 
1% 
Apart from diabetes, significant co-existent medical diseases were seen in two patients including hypertension in one 
patient and another patient had pulmonary tuberculosis. 5 patients underwent endoscopic interventions. One patient had pancreatic 
sphincterotomy, one patient had extracorporeal shock wave lithotripsy (ESWL) with stent, one patient had CBD stenting and two 
other patients underwent pancreatic stenting. All these patients had poor control of pain following stenting. The patient who 
underwent ESWL with stent had developed pseudoaneurysm of splenic artery and subsequently had massive haemoptysis and 
haematochezia. 
Among the surgical intervention, 91 patients (91%) underwent drainage procedures and 9 patients (9%) underwent some 
resectional procedures. Longitudinal pancreaticojejunostomy was performed in the majority of patients (n= 70). Pancreatogastrostomy 
was done in 4 patients. 13 patients underwent Local resection of head and longitudinal pancreaticojejunostomy (LR-LPJ / Frey’s 
procedure). Puestow’s procedure was done in two patients. One patient had excision of pseudo aneurysm, drainage of the pseudocyst 
and Roux-n-y pancreaticojejunostomy for gastro duodenal artery pseudo aneurysm bleeding into pseudocyst in head region. One 
patient had transcystic ligation of splenic artery pseudo aneurysm and cystogastrostomy for splenic artery pseudo aneurysm bleeding 
into pseudocyst in body region. 
Among the resection group, 6 patients underwent distal pancreatectomy, and two patients had Whipple’s resection for 
suspicion of head malignancy, which subsequently turned out to be chronic pancreatitis. Distal pancreatectomy, excision of 
pseudoaneurysm, closure of diaphragmatic and colonic rent and colostomy done for a case of splenic artery pseudoaneurysm eroding 
into diaphragm, bronchus and colon presenting with massive haemoptysis and haematochezia. One patient had excision of 
pseudoaneurysm and central pancreatectomy for splenic artery pseudoaneurysmal bleed.  Table.2 summarizes the surgical 
interventions performed for 100 patients. 
Table. 2. Surgical interventions adopted in 100 patients. 
 Interventions Percent (%) 
Drainage 
    Longitudinal Pancreaticojejunostomy 
91 
71 
         LPJ alone 
         LPJ + Choledochoduodenostomy 
         LPJ+ Cholecystectomy 
         LPJ + Pseudocyst / Ext. drainage 
         LPJ + enteroenterostomy  
         Transcystic excision of pseudoaneurysm + Cystogastrostomy + LPJ 
    LR-LPJ / Frey’s procedure 
    Pancreatogastrostomy 
          PG alone  
           PG + Cholecystectomy 
    Puestow’s procedure 
    Excision of  pseudoaneurysm + Ext.drainage of Pseudocyst + Roux-n-y PJ 
Resection 
    Distal pancreatectomy 
      DP alone 
      DP + LPJ  
      DP + Roux-n-Y PJ 
     DP + Excision of Pseudoaneurysm  
    Whipple’s resection 
    Excision of pseudoaneurysm + Central pancreatectomy 
            
57 
 6 
 3 
 3 
 1 
 1 
13 
 4 
 3 
 1 
 2 
 1 
 9 
 6 
 1 
 1  
 1 
 2 
 2 
 1 
 
ASSOCIATED COMPLICATIONS: 
  
 In 34 patients (34%), associated complications were identified before or during operation. 10 patients had associated 
Pseudocysts, 8 patients were treated with LPJ alone. cystogastrostomy was done in 1 patients and cystojejunostomy was done in one 
patient. Six patients who had terminal bile duct strictures were treated by biliary diversion i.e. choledochoduodenostomy along with 
longitudinal pancreaticojejunostomy. 3 patients were presented with pancreatic ascites. Two patients were treated by 
Pancreaticogastrostomy alone.  One patient had rupture of pancreatic duct in the tail region with pancreatic duct stricture in the head 
region. Distal pancreatectomy and Roux-n-y pancreaticojejunostomy was done for this patient. Four patients had associated pancreatic 
abscess. Three patients were treated with distal pancreatectomy and Roux-en-y pancreaticojejunostomy and one patient was treated 
with external drainage and LPJ. Five patients had associated gall stone disease and were treated with cholecystectomy. One patient 
had tuberculous ileocaecal mass and was treated with enteroenterostomy. Associated complications are shown in Table. 3. 
          
 
 
 
 
 
 
 
 
 
 
Table.3 Management of complications associated with chronic pancreatitis 
 
 
 
 
  Patients’ characteristics of both alcoholic chronic pancreatitis (ACP) and tropical chronic pancreatitis (TCP) were 
analyzed. Among the tropical chronic pancreatitis group, mean age was 31.6 years. Males: Females ratio was 1.76:1. Pain was present 
Complications Pts Management
Pseudocyst 
 
 
Bile duct stenosis 
Haemorrhage 
 
 
 
Pancreatic Ascites 
 
Pancreatic abscess  
 
Gall stone 
 
Ileocaecal mass 
10 
 
 
 6 
 5 
 
 
 
3 
 
4 
 
5 
 
1 
 8  LPJ alone 
 1   LPJ + Cystogastrostomy  
 1  LPJ + Cystojejunostomy  
  6  Choledochoduodenostomy 
 1    Excision of  pseudoaneurysm + Ext.drainage off Pseudocyst + Roux-n-y PJ 
1 Transcystic excision of pseudoaneurysm + Cystogastrostomy 
1 Excision of pseudoaneurysm +  Central pancreatectomy 
2 DP + Excision of Pseudoaneurysm  
2    Pancreaticogastrostomy 
1    DP with Roux-n-y PJ 
3    DP + Roux-n-Y PJ 
1    LPJ + External drainage 
4    LPJ + Cholecystectomy 
1     PG + Cholecystectomy 
1     Enteroenterostomy 
in 97% of patients at the time of presentation.  Jaundice due to biliary stricture was present in two patients; pseudocyst and pseudo 
aneurysm was present in four and two patients respectively. Mean pancreatic duct diameter was 9.1 mm; Ductal stones were present in 
93.8% of patients. 13.6% of patients were presented with inflammatory head mass. Among the surgical intervention in TCP group 
71.2% of patients underwent longitudinal pancreaticojejunostomy, 13.6% of patients underwent local head resection and longitudinal 
pancreaticojejunostomy (LR-LPJ or Frey’s procedure), 3 patients had pancreaticogastrostomy, 2 patients had Puestow’s procedure, 4 
patients had distal pancreatectomy and one patient underwent central pancreatectomy.                      
 Among the Alcoholic chronic pancreatitis group, mean age was 42.9 years which was significantly higher compared to 
TCP group (31.9). All were males. 93.5% of patients were presented with pain. 6.5% of patients had jaundice. Pseudocysts and 
pseudoaneurysm were present in six and two patients respectively. Suspicious of malignancy was present in two cases. Mean 
pancreatic duct diameter was 9.3 mm which is similar to TCP group. Inflammatory head mass was present in 22.6% of patients. 
Ductal stones were present in 80.6% of patients. 67.7% of patients underwent longitudinal pancreaticojejunostomy. 13% of patients 
had LR-LPJ. One patient had pancreaticogastrostomy. One patient had excision of pseudoaneurysm and Roux-n-y 
pancreaticojejunostomy. Two patients had distal pancreatectomy. Two patients were subjected to Whipple’s resection based on the 
suspicious of malignancy. In a comparative analysis, patients in tropical chronic pancreatitis were  
 
 
significantly younger than in alcoholic chronic pancreatitis. Pseudocysts were significantly more common in the alcoholic chronic 
pancreatitis. Suspicion of malignancy is significantly more common as an indication for surgery in the alcoholic pancreatitis. The 
comparative analysis is shown in Table.4. 
 
Table 4. The comparative analysis of TCP and ACP 
 
Parameters TCP ACP P Value 
No. of patients 
Age (mean ± s.e.m)  
Sex (Male: Female) 
Pain 
Complications 
   Biliary stricture 
   Pseudocyst 
   Pseudoaneurysm 
   Suspicious of malignancy 
PD diameter (mm) (mean) 
Ductal stones  
Inflammatory head mass 
Surgical intervention 
Drainage procedures 
   LPJ 
   LR-LPJ 
   PG 
   Others 
Resections 
   Distal pancreatectomy 
   Whipple’s 
    Central pancreatectomy 
66 
31.9 ± 12.9 
37:29 
64 (97%) 
 
2 (3%) 
4 (6%) 
3 (4.5%) 
0 
9.1 
61 (93.8%) 
9 (13.6) 
 
 
47 (71.2%) 
9 (13.6%) 
3 (4.5%) 
0 
 
               4   (6%) 
0 
1 
31 
42.9 ± 8.1 
All Males 
29 (93.7%) 
 
                3  (9.7%) 
6 (19.3%) 
2 (6.5%) 
2 (6.5%) 
9.3 
25 (80.6%) 
7 (22.6%) 
 
 
21 (67.7%) 
4 (13%) 
1 
1 
 
                   2     (6.5%) 
2 
0 
- 
0.001 
- 
0.4 
 
0.4 
0.04 
0.5 
0.04 
- 
0.09 
0.27 
 
 
0.73 
0.6 
0.6 
- 
 
0.4 
0.04 
- 
 
 
EARLY OPERATIVE MORBIDITY AND MORTALITY: 
  
 There was no difference between hospital mortality (1.4% Vs 0%) between 
drainage and resection groups. Significant morbidity after pancreatico -jejunostomy 
included pancreatic fistula (2%), delayed gastric emptying (1%), and gastrointestinal 
hemorrhage due to pancreatico jejunostomy anastomotic bleeding (1%). The latter patient 
required reoperation. Patient died on d 24. Among resectional procedures, one patient had 
pancreatic fistula following distal pancreatectomy and one patient had biliary peritonitis 
due to bilioenteric anastomotic leak following Whipple’s resection. The latter required 
reoperation and fared well after second surgery. Two patients in the drainage group and 
one patient in resection group developed pulmonary complications - atelectasis. One 
patient had delayed gastric emptying after distal pancreatectomy, which resolved with 
conservative treatment. One patient developed subphrenic abscess following distal 
pancreatectomy, which was treated with ultrasound guided drainage and antibiotics. Six 
patients in the drainage group and four patients in resection group had minor wound 
infection and one patient had urinary tract infection following LR-LPJ.  
There were a total of 24 complications in 18 patients (morbidity 18%) within the postoperative period. The presence of a 
pancreatic fistula was defined by the drainage output of greater than 50 ml abdominal fluid per day with an amylase content of greater 
than 3 times the serum value (> 300 units/ liter). Non operative management was used for pancreatic fistula and drain track infection. 
Two patients required reintervention. One patient required a relaparotomy for gastrointestinal bleed due to pancreaticojejunal 
anastomotic bleed and subsequently died.  
 
Another patient required relaparotomy for bile peritonitis and subsequently recovered. 30-day In-Hospital mortality was 
1%. Postoperative complications and their management are shown in Table 5. 
Table.5. Postoperative Complications and management  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Complications Drainage Resection Management 
Pulmonary 
  Atelectasis 
Gastrointestinal 
  Pancreatic fistula 
  GI Hemorrhage 
  Delayed gastric emptying 
  Subphrenic/ Pelvic abscess 
  
 Bile leak 
Others 
  Septicemia 
  Wound infection 
  UTI    
 
2 
 
2 
1 
1 
- 
 
- 
 
- 
6 
1 
 
1 
 
1 
- 
1 
1 
 
1 
 
2 
4 
- 
 
 
Antibiotics 
 
 
 
Conservative 
 
Reoperation 
 
Conservative 
 
Antibiotics And  
USG guided 
Drainage 
 
Reoperation 
 
 
 
Antibiotics 
 
Conservative 
 
Antibiotics 
  
 
 
 
 
 
 
 
 
In a comparative analysis between drainage and resection group, hospital morbidity was significantly higher in resection 
group (p= 0..01, OR  = 7.5, 95% CI = 1.5-39). No significant difference was found in hospital mortality and reoperation. The 
operative procedures performed and hospital course after each type of surgery are summarized in the Table 6. 
Table 6. Operative Procedures Performed and Hospital Course 
 
 
Procedures No. of Patients 
Hospital 
Mortality 
Hospital 
morbidity 
 
     Mean 
Hospital stay 
Reoperation 
(no.) 
Mean
 follow -up 
(months) 
Drainage 
       LPJ 
       Frey’s 
       PG 
       Puestow’s 
       Excision of  PA+ 
       Roux-n-y PJ 
Resection 
       DP 
       Whipple 
       Central pancreatectomy  
       
     71 
13 
4 
2 
1 
 
              
6 
2 
1 
 
1(1.4%) 
- 
- 
- 
- 
 
 
- 
- 
- 
 
7(9.8%) 
5(38.5%) 
- 
- 
1(1/1) 
 
 
3(50%) 
2(2/2) 
- 
 
11.3 
13.5 
10.8 
16.0 
43.0 
 
 
11.8 
16.0 
10.0 
 
2 
- 
- 
- 
- 
 
 
- 
1 
- 
 
47 
17.1 
31 
144 
18 
 
 
40.5 
54.0 
24.0 
RELIEF OF PAIN: 
 
 
Long-term pain relief was good in 87 patients (87 %), fair in 11patients (11 %) and poor in 2 patients (2 %). The results of 
the different types of operation on long-term pain relief are presented in Table 7. The highest rate of pain relief was achieved after LR-
LPJ or Frey’s procedure (92.3%), followed by distal pancreatectomy (85.7%) and Longitudinal pancreatico jejunostomy (83.1%). 
However, when compared, differences between the various surgical procedures concerning pain relief were not significant.  
 Of 81 patients who had been operated for intractable pain, on follow-up discounting early and late deaths, 65 (84%) of the 
77 surviving patients had complete relief of pain and 8 (10%) patients had better control of pain and able to attend to their normal 
preillness daily routine. 4 (5%) patients had persistent epigastric pain requiring analgesics and not satisfied with the results of surgery. 
There was no significant difference in the pain relief between drainage and resection group (p= 0.73). Table.7 summarizes the degree 
of pain relief after various procedures for chronic pancreatitis. 
 
Table 7. Pain relief in patients undergoing surgery for chronic pancreatitis 
 
 
 
 
PANCREATIC INSUFFICIENCY: 
Pain Relief Operative 
Procedures 
No. of Patients Percentage (%) 
  
Mean follow –up 
          (months) 
Drainage  
    LPJ 
    Frey’s 
    PG 
    Puestow’s 
    Excision of PA+ Roux-n-y PJ 
Resection 
    DP 
    Whipple 
    Central pancreatectomy 
 
59/71 
12/13 
4/4 
1/2 
1/1 
 
5/6 
2/2 
1/1 
 
83.1 
92.3 
3/4 
1/2 
1/1 
 
83.3 
1/2 
1/1 
 
47 
17.1 
31 
144 
18 
 
40.5 
54.0 
24.0 
 The overall insulin requirement was decreased significantly after operation both at 3 months and at 3.6 years.. Two of 
thirty-three patients who had diabetes were able to stop insulin therapy and control their diabetic status with diet alone and four of 
patients had obtained euglycemic status and diabetic free status. 18 of 34 patients who were dependent on insulin could be able to stop 
insulin therapy and control their diabetic status with oral hypoglycemic agent therapy (OHA) alone. There was significant reduction in 
the requirement of insulin dose after surgery (18.6 Vs 30.8, p < 0.001). There was a significant decrease in fasting and postprandial 
blood glucose levels in diabetic patients after surgery, 147.6 Vs 204.8 and 232.4 Vs 325.3 respectively. Table 8 summarizes the dose 
of insulin required to control the diabetes and the blood glucose levels on follow-up.  
 
 
Table.8. The insulin requirement and blood glucose levels in 54 diabetic patients subjected for surgery at mean 3.6 
years follow-up  
 
Parameters Before surgery After surgery P value 
 
Units/day per patient, mean(± SE) 
Fasting (mg/dl) 
Postprandial (mg/dl) 
 
30.8 (3.8) 
204.8 (11.5) 
325.3 (16.8) 
 
18.5 (3.4) 
147.6 (8.1) 
232.4 (12.2) 
 
 
0.001 
 
0.001 
 
0.001 
 
 
 
 Pancreatic insufficiency was slightly improved in patients subjected for longitudinal pancreatico jejunostomy group, while 
it was not changed in LR-LPJ group. Among the resection group, endocrine insufficiency worsened in patients who had distal 
pancreatectomy and unchanged in other operations. Steatorrhea improved in six of 17 patients after surgery and remained unchanged 
in four. Four new cases of malabsorption were detected postoperatively in addition. Pancreatic insufficiency after surgery was 
summarized in Table 9. There was no difference in pancreatic insufficiency between resection and drainage group.  
 
 
Table 9. Pancreatic Insufficiency after Surgery for Chronic Pancreatitis 
 
 
                             
   
 On follow-up, there was significant reduction in number of patients experiencing pain after surgery (96% Vs 21%, p= 
0.001). Similarly, there were significant reduction in number of patients requiring injectable analgesics (87% Vs 7%, p= 0.001), 
number of patients requiring enzyme replacement (80% Vs 54%, p= 0.001), number of patients employed (9% Vs 82%, p= 0.001) and 
the number of patients dependent on insulin (34% Vs 13%, p= 0.001). But there was no significant change in diabetic status and the 
PANCREATIC INSUFFICIENCY
Diabetes Steatorrhea 
 
MEAN FOLLOW-UP 
(months) 
Preop Postop Preop Postop 
 
 
 
PROCEDURES 
No. of pts (%) No. of pts (%) No. of pts (%) No. of pts (%) 
 
Drainage 
   LPJ 
   Frey’s 
   PG 
   Puestow’s 
   Excision of PA+  
   Roux-n-y PJ 
Resection 
   DP 
  Whipple 
  Central  pancreatectomy 
 
 
 
 
41/71 
7/13 
1/4 
2/2 
1/1 
 
 
  1/6 
1/2 
- 
 
 
 
 
57.7 
53.8 
25.0 
2/2 
1/1 
 
 
16.7 
1/2 
- 
 
 
 
 
33/71 
7/13 
1/4 
1/2 
0 
 
 
1/6 
1/2 
0 
 
 
 
 
46.5 
53.8 
25.0 
1/2 
0 
 
 
16.7 
1/2 
0 
 
 
 
 
9/71 
3/13 
2/4 
0 
0 
 
 
1/6 
2/2 
0 
 
 
 
 
12.7 
23.1 
- 
- 
- 
 
 
16.7 
2/2 
- 
 
 
 
 
5/71 
3/13 
0 
0 
0 
 
 
0 
2/2 
0 
 
 
 
 
7.0 
23.1 
- 
- 
- 
 
 
0 
   - 
- 
 
 
 
          47 
17.1 
31 
144 
18 
 
 
          40.5 
54.0 
24.0 
 
 
number of patients having steatorrhoea. Table. 10 summarizes overall results on pain relief, endocrine and exocrine insufficiency and 
employment status. 
 
Table. 10. Overall outcome of surgery for chronic calcific pancreatitis. 
 
The Alcohol withdrawal rate was 90.3%. There was a significant reduction in alcohol consumption after surgery with 3 out 
of 31 (9.7%) of patients was continuing to drink alcohol beyond 1 year after surgery (p < 0.0001).  There was significant difference in 
pain score between those who continued to drink and those who abstained. Similar to overall results, the subgroup analysis also 
showed significantly improved results in both alcoholic and tropical chronic pancreatitis group.  
In Alcoholic chronic pancreatitis, there was improvement in number of patients experiencing pain (93.5% Vs 22.6%, p= 
0.001), number of patients requiring injectable analgesics for pain relief (80.6% Vs 6.5%, p= 0.001), number of patients requiring 
pancreatic enzyme replacement (90.3% Vs 64.5%, p=0.01), number of patients having diabetes (64.5% Vs 51.6%, p= 0.01), number 
Grand Total 
 
 Before 
Surgery 
(%) 
After 
Surgery 
(%) 
 
P value [OR (95% CI)] 
 
 Pain 
 
Injectable Analgesics 
 
Requirement for Enzyme 
Replacement 
 
 Diabetes 
 
 Steatorrhoea 
 
Employed 
 
Insulin Dependency 
 
96 
 
84 
 
80 
 
 
54 
 
17 
 
9 
 
34 
 
21 
 
7 
 
54 
 
 
44 
 
10 
 
82 
 
13 
 
 
 
0.001 [90 (28-329)] 
 
0.001 [70 (25-201)] 
 
0.001[3(2-7)] 
 
 
0.12 
 
0.15 
 
0.001[47(18-120)] 
 
0.001[3(2-8)] 
 
 
of patients employed (12.9% Vs 77.4%, p= 0.001) and number of patients dependent on insulin (33.5% Vs 12.9%, p= 0.05). There 
was no significant change in number of patients having steatorrhoea (25.8% Vs 9.7%, p=0.78). 
In tropical chronic pancreatitis, there was significant improvement in number of patients experiencing pain (97% Vs 
19.7%, p= 0.001), number of patients requiring injectable analgesics for pain relief (86.4% Vs 6.1`%, p= 0.001), number of patients 
requiring pancreatic enzyme replacement (74.2% Vs 47%, p=0.01), number of patients employed (7.6% Vs 83.3%, p= 0.001) and 
number of patients dependent on insulin (31.8% Vs 12.1%, p= 0.05). There was no significant change in number of patients having 
diabetes and steatorrhoea. Outcome analysis, according to etiological classification was summarized in Table 11. 
Table 11. Outcome of Surgery in chronic calcific pancreatitis according to etiological classification. Data were 
expressed as number of patients. 
 
 
Alcoholic pancreatitis (31) Tropical Pancreatitis (66) 
 
Before surgery    
(%) 
After surgery 
(%) 
P Value OR 
(95 % CI) 
Before 
Surgery 
(%) 
After surgery 
(%) 
P  
Value 
OR 
(95 % CI) 
Misused alcohol 
 
Pain 
 
Injectable Analgesics 
 
Requirement for Enzyme 
Replacement 
 
Diabetes 
 
Steatorrhoea 
 
Employed 
 
Insulin Dependency 
31 (100) 
 
29 (93.5) 
 
25 (80.6) 
 
28 (90.3) 
 
 
20 (64.5) 
 
8 (25.8) 
 
4 (12.9) 
 
11 (35.5) 
3 (9.7) 
 
7 (22.6) 
 
2 (6.5) 
 
20 (64.5) 
 
 
16 (51.6) 
 
3 (9.7) 
 
24 (77.4) 
 
4 (12.9) 
 
 0.001 
 
0.001 
 
0.001 
 
0.01 
 
 
0.01 
 
0.78 
 
0.001 
 
0.05 
 
- 
 
49 (8 - 399) 
 
60 ( 10–500) 
 
5 (1 – 27) 
 
 
5 (1 – 27) 
 
- 
 
23.1 (5 – 115) 
 
3 (1 – 15) 
- 
 
64 (97) 
 
57 (86.4) 
 
49 (74.2) 
 
 
33 (50) 
 
9 (13.6) 
 
5 (7.6) 
 
21 (31.8) 
- 
 
13 (19.7) 
 
4 (6.1) 
 
31 (47) 
 
 
26 (39.4) 
 
7 (10.6) 
 
55 (83.3) 
 
8 (12.1) 
- 
 
0.001 
 
0.001 
 
0.001 
 
 
0.22 
 
0.59 
 
0.001 
 
0.01 
- 
 
130(26 – 887) 
 
98 (26 -420) 
 
3 (2 - 7) 
 
 
- 
 
- 
 
61 (18 -223) 
 
3 (1- 9) 
 
Patients were considered to be in good health had lower alcohol and regular analgesic requirements for insulin and 
pancreatic enzyme supplementation. Patients considered to poor health category had continued use of alcohol and analgesic use and 
high incidence of endocrine and exocrine insufficiency characterized this group. Over all health   assessment was classified as 
excellent in 8 patients (8%), good in 78 patients (78 %), fair in 11 (11%) and poor in 3 (3%). Overall health status is shown in 
Table.12.    
 
 
 
 
 
Table.12. The Overall health  status on follow-up in 100 patients  
 
 
Functional Results Follow-up (Months) 
Excellent Good Fair Poor 
6-24 4 39 2 3 
25-60 2 28 1 - 
61-120 1 6 8 - 
121-180 1 5 - - 
Total (%) 8(8%) 78(78%) 11(11%) 3(3%) 
 
 
 Diagram showing the health status: 
0
10
20
30
40
50
60
70
80
Excellent (8%) Good (78%) Fair (11%) Poor (3%)
 
 
 
QUALITY OF LIFE 
 
  Although no formal instrument measuring quality of life was used, quality of life after surgery was inferred from the results 
graded both by degree of pain relief and activity status. The median number of hospital admission fell after surgery for all procedures 
from 2 admissions per year to none by 12 months after surgery which was maintained during follow-up. There was a significant 
increase in those in regular employment after surgery. 82 of 86 (95.3%) patients rated as in good health were employed (full time), 
whereas only 6 of 11 (54.5%) in fair health and none in poor health were employed. The proportion of patients able to work a function 
normally after surgery increased markedly (9% vs. 82%, P<0.0001); 79% of patients unable to work or to function normally prior to 
surgery were able to do so after surgery.  
 
 
 
WEIGHT MAINTENANCE OR GAIN 
 
  
 87 Patients gained weight during the follow-up.  The mean weight gain was 3 Kg. 
Five patients maintained their weight. Eight patients had weight loss with the mean of 6.2 
Kg. There was significantly weight gain in the postoperative period. (p= 0.001,OR= 77, 
95% CI = 28-220). 
 
RE - HOSPITALIZATIONS: 
 
 19 patients required one or more hospital admissions during follow-up. 9 patients admitted for pain abdomen related to 
acute exacerbation of chronic pancreatitis, which was treated conservatively. Two patients admitted with diabetes mellitus related 
problems. Three patients had oesophagitis/gastritis related problems. One patient had been admitted for repair of incisional hernia. 
Three patients had mortality owing to malignancy of head of pancreas. These patients had pain abdomen consequence of unsuspected 
malignancy intraoperatively. One of these patients had gastric outlet obstruction symptoms. All these patients had biopsy proven 
malignancy and had disseminated malignancy at the time of diagnosis. Two patients died 11/2 years and one patient died at 1 year 
after surgery.  One patient had ruptured splenic artery pseudo aneurysm, gastric perforation, splenic infarction, necrosis of pancreatic 
parenchyma and colonic perforation. This patient was operated after resuscitation. Distal pancreatectomy, Splenectomy, excision of 
pseudo aneurysm, necrosectomy, closure of gastric perforation and transverse colostomy was performed. The patient was on 
prolonged postoperative ventilator support and subsequently died.  Reasons for re - hospitalization are listed in Table. 13. 
      Table. No.13. Re - hospitalizations details: 
Reasons No. of patients 
 
Admission related to chronic pancreatitis 
Pain abdomen 
Diabetes  
Unsuspected / Missed Malignancy 
Admission for other conditions 
Oesophagitis/Gastritis 
GI Bleed 
Incisional Hernia 
 
 
 
9 
2 
3 
 
3 
1 
1 
 
 
DISCUSSION 
 
According to the conventional wisdom, an operative procedure for chronic 
pancreatitis, as a palliative measure on an already functionally impaired gland, it should 
be as conservative as possible to limit the occurrence especially of endocrine failure. 
Contrary to this, aggressive approach has been advocated by some series. Berney et al 3 
reported pancreatic resection for severe chronic pancreatitis in 68 patients and shown that 
resection was safe and had long-term results of pain control. 
Our series, based on the conventional concept, to preserve as much functioning 
parenchyma and islet cells as possible, only nine patients were subjected for resectional 
procedures. 8 of the 9 patients had pain relief; four of nine patients had endocrine 
insufficiency. 
Longitudinal pancreatico jejunostomy (LPJ) is safe. We had one postoperative 
death with LPJ (mortality 1%).  Many authors have reported low mortality rate (0 %) 10. 
During follow up, 3 patients (3%) died at a mean of thirteen months after the operation, 
which is comparable with reported rate 11. Pain relief was classified as good in 65 of 77 
patients (84%) who underwent surgery for intractable pain.  
Our study showed that operative intervention (both drainage and resection) can achieve pain relief and a better quality of 
life in selected patients. Frey’s procedure appears to achieve highest pain relief (92.3%), Careful patient selection presumably based 
on structural changes within the pancreas and adjacent organs is the key factor in achieving good results. Although our group fully 
accepts the concept of ‘burn out’ of the disease leads to eventual spontaneous relief of the chronic pain. In our study, operative therapy 
not only led to long lasting pain relief in the majority of patients operated, but also resulted in a significant increase in the proportion 
of patients able to work or function normally in a society from 9% to 82%, according to a better quality of life. 
In our study, among the alcoholic chronic pancreatitis, 4 of 31 patients (12.9%) continued to consume alcohol. Most of 
these patients fell into poor or fair health categories. Despite uncertainty as whether abstinence of alcohol truly results in diminished 
pain, there is little debate that abstinence should be recommended. Lankisch et al and Layer et al demonstrated that only 13% to 20% 
of deaths in patients with chronic pancreatitis are directly related to pancreatitis 6, 7. The majority of deaths in these patients occur as 
a result of diseases that are related to tobacco or alcohol.  
      Although higher proportion of patients with tropical chronic pancreatitis patients had pain relief following surgery, we did 
not find any correlation between the pain relief in alcoholic pancreatitis and those who were not alcoholic. This result is similar to that 
reported by Brinton et al 40 who reported results of lateral pancreaticojejunostomy in 39 patients. This is in contrast to report by Sato 
et al, who found that over mean period of 9.1 years only 50% of patients with alcoholic pancreatitis had a good result after surgery 
compared to 83% of those who had nonalcoholic pancreatitis 41. Another report by Sharma et al 42 found that 88% of patients of 
patients with nonalcoholic chronic pancreatitis had immediate and lasting pain relief.  
Studies reporting the incidence of alcohol abuse and results of surgery after pancreaticojejunostomy for chronic 
pancreatitis are shown in Table. 14. 
 
 
 
 
Table.14. Incidence of alcohol abuse and results of surgery after pancreaticojejunostomy for chronic pancreatitis. 
 
 In our study, the type of surgery or the etiology of chronic pancreatitis did not 
influence the long-term outcome of patient with chronic pancreatitis. This could be partly 
explained by the nature of the disease. The etiology and perception of pain in chronic 
Relief of painStudy Year No. Alcohol abuse 
(%) 
Operative mortality (no.) (%) Late deaths (No.) (%) 
Poor Fair Good 
 
Greenlee et al 
Hakaim et al 
Sharma et al  
Present study 
 
1990 
1994 
1998 
 
100 
50 
58 
100 
 
100 
 60 
   0 
  31 
 
4 (4) 
0 (0) 
4 (7) 
1 (1) 
 
3 (3) 
5 (10) 
4 (7) 
3 (3) 
 
22 
2 
8 
5 
 
16 
24 
12 
10 
 
37 
60 
79 
84 
pancreatitis is definitely multi-factorial and it is influenced by a variety of factors 
including the social and cultural dynamics, co-morbid illnesses and continued use of 
alcohol. 
  Our group of patients who had poor relief of pain, continued to indulge in alcohol 
consumption and because alcohol withdrawal could not be obtained in those patients, we 
have not employed operative strategies for this set of patients.  
When the health status of the patient was analyzed in greater details, health status was considered Excellent in 8 (8%), 
good in 78 (78%), fair in 11 (11%) and poor in 3(3%) of patients who were alive at review. 
 
ENDOCRINE AND EXOCRINE INSUFFICIENCY: 
 
The operation resulted in an improvement of patient’s diabetic status, with about 24 of 33patients (72.7%) who were 
dependent on insulin before surgery, being able to stop taking insulin and euglycemic status was achieved with oral hypoglycemic 
drugs or by diet alone. Exocrine pancreatic dysfunction was improved in 50% of patients who had steatorrhea preoperatively. 
Similar experiences have been reported from India in patients with tropical calcific pancreatitis. Sidhu et al have shown 
that there was significant improvement of endocrine insufficiency and slight improvement of exocrine insufficiency in patients with 
tropical chronic pancreatitis undergoing modified Puestow procedure in a long-term follow-up study 17. Similar experience from 
Western studies by Nealon et al also showed that occurrence of endocrine and exocrine insufficiency can be delayed by longitudinal 
pancreaticojejunostomy 16.  In our study, there was no difference in pancreatic insufficiency between and resection group which is 
similar to a report from Mayo clinic study by Sakorafas et al 28. 
 
ASSOCIATED COMPLICATIONS: 
 
  In 14 patients (14%), LPJ was combined with another procedure to manage a complication of chronic pancreatitis.  10 
patients (10%) had associated pseudocysts. 8 patients with pseudocysts were managed with longitudinal pancreaticojejunostomy 
alone.  This study further supports the concept of Nealon et al that most pseudocysts located in the head and body of the gland can be 
incorporated into the LPJ 11.     
 6 Patients (6%) had terminal biliary stenosis managed by biliary enteric diversion: i.e. Choledocho 
duodenostomy. The incidence was similar to that reported in literature 68.  3 Patients had pancreatic ascites, which was initially 
managed conservatively. Two required pancreaticogastrostomy and another required distal pancreatectomy and splenectorny. It is not 
necessary to attempt excision of the fistulous track because it will close spontaneously after adequate decompression of the pancreatic 
duct.  This experience emphasizes the common occurrence of associated complications that must be considered in the preoperative 
evaluation and when possible, corrected during the surgical procedure. We had three late deaths related to unsuspected pancreatic 
cancer. These patients presented with markedly unrelieved pain in the follow-up. This incidence is similar to that reported by 
Markowitz et al in which they have shown that unsuspected or missed malignancy of head of pancreas is an important cause of 
persistent pain after decompression procedure 34. This further emphasizes that one should have a high index of suspicion of pancreatic 
cancer in patients presenting with head mass. 
Patients whom underwent endoscopic intervention had poor control of pain and this modality may be associated with major 
morbidity and life threatening complication. In our study, we had one major complication, splenic artery pseudoaneurysm with 
diaphragmatic and bronchial erosion and presenting with haemoptysis following ESWL and pancreatic stenting and other patients who 
underwent stenting also had poor short-term results. 
 
QUALITY OF LIFE AFTER SURGERY FOR CHRONIC PANCREATITIS:  
 Although no formal instrument measuring quality of life was used, quality of life after surgery was inferred from the 
results graded both by degree of pain relief and activity status. There was significant decrease in number of hospital admissions after 
surgery (2 versus none, p <0.05), and significant increase in regular employment and able to work a function normally (9% versus 
82%).  
  
 
 
 
 
FUTURE DEVELOPMENTS: 
  
Genetic abnormalities in chronic pancreatitis: 
 
 It is now well established that there are genetic abnormalities in chronic 
pancreatitis. The specific gene mutations associated with different forms of chronic 
pancreatitis, include:  
Cationic trypsinogen (PRSS1) gene mutation in hereditary pancreatitis. 
Serine protease inhibiter (Kazal type 1 (SPINK1)) gene mutation in idiopathic chronic 
pancreatitis. SPINK 1 gene mutation has also been reported in tropical and alcoholic 
chronic pancreatitis. ] Cystic fibrosis transmembrane regulator gene mutation (CFTR) in 
chronic pancreatitis associated with cystic fibrosis. 
 
 Genetic studies in the diagnosis of chronic pancreatitis:  
 
 Conventionally, hereditary chronic pancreatitis is diagnosed only when one or 
more members of the family are affected by this criterion, a number of cases of hereditary 
chronic pancreatic can be missed because it may occur even when no other family has the 
disease. This group is thus labelled idiopathic chronic pancreatitis. However, PRSS 1 
gene mutation has been detected in approximately 10% of patients with idiopathic 
chronic pancreatic without a family history of chronic pancreatitis. Since PRSS 1 gene 
mutation occurs in hereditary chronic pancreatitis, these patients with a negative family 
history but evidence of the gene mutation should be labelled hereditary chronic 
pancreatitis 98. Another 10% of patients with idiopathic chronic pancreatitis have the 
R122 H trypsinogen gene mutation. These patients get the diseases much earlier (mean 
age 14 ± 3 years) compared with those without the R122 H trypsinogen gene mutation 
(mean age 38 ± 2 years).  
 
 
Genes as potential markers and target in chronic pancreatitis:  
 
 
In 2002, a near complete sequencing of the human genome99   was achieved. This allowed, with the help of novel 
technologies such as DNA array, the simultaneous analysis of a large number of genes and the identification of disease-specific genes. 
The first study using DNA array technology in CP was conducted by Fries et al.100.  On screening 5600 human genes, 6 genes 
specific to CP were identified. These showed a significantly increased expression in CP compared to the normal pancreas as well as 
pancreatic cancer.100 These 6 genes included the cartilage oligomeric matrix protein (COMP), the cysteine-rich secretory protein-3 
(CRISP3) and tryptase.10  
 Tryptase is a serine protease, stored in the mast cells, which is known to induce the synthesis of type 1 collagen by human 
fibroblasts and stimulate fibroblasts proliferation and chemotaxis. Mast cells are well-known effector cells of immediate-type allergic 
reaction. A cross-linking of receptor-bound IgE on the mast cells membrane by specific allergens leads to the release of preformed 
mediator. Though these and other mechanisms, mast cells exert their role in allergic reactions as well as in acute and chronic 
inflammatory settings. In CP, there is a significant increase in the total number of mast cells compared to the normal pancreas101. 
Interestingly, there is also a correlation between the number of mast cells, and the extent of fibrosis and intensity of inflammations101. 
Furthermore, IgE-dependent mast cells activation is higher in CP than in normal pancreas; however, there is no difference in the 
number of mast cells or IgE- positive mast cells between CP of different aetiologies. In CP, mast cells are mostly located in the fibrous 
tissue and around the regenerating ducts, which are positive for the c-kit receptor----, the receptor for the mast cells growth factor SCF 
(stem cell factor). 101 It is thought that mast cells are a relevant component of the inflammatory infiltrate in CP, which might play a 
role in tissue destruction and remodeling in this disease. 
 The CRISP3 is a member of the cysteine-rich secretory protein family, detected in several human tissues, predominantly in 
the salivary gland, pancreas and prostate. In addition, CRISP3 is considered a defence-associated molecule in mammals. In CP, there 
is an increased expression of this molecule, which was mainly localized in the cytoplasm of dedifferentiating acinar cells and in 
tubular complexes100 Interestingly, CRISP3 expression was weak to absent in cancer cells, and normal acinar and ductal cells in 
pancreatic cancer as well in the normal pancreas. 100 The predominant localization of CRISP3 in Acinar cells dedifferentiating into 
tubular complexes as well as in these tubular structures itself suggests that this molecule has some role in the pathophysiology of CP. 
 The third gene which is selectively upregulated in COMP. COMP is a member of the thrombosponding family of 
extracellular matrix proteins. It was discovered initially in the cartilage of several human organs. In CP, expression of COMP was 
evident in the cytoplasm of the degenerating acinar cells, but not in the tubular complexes, or in normal acinar or ductal cells. 101 In 
additions, COMP is also present in the fibrotic tissue in CP. Preferential expression of COMP in the dedifferentiating acinar cells in 
CP suggests a potential role of this gene in causing degeneration and dedifferentiation of the Acinar cells.101 COMP might thus serve 
as a marker for tissue destruction and disease activity in CP.    
 
Tropical Chronic Pancreatitis: 
 
While the molecular basis of alcoholic and idiopathic CP has been extensively studied, it has not been compared with 
tropical CP.102 
 Among various causes, nerve alteration and neuroimmune interaction have been suggested to participate in causing pain in 
CP. The German group compared neural changes and the pattern of Perineural inflammatory cell infiltrates in three different 
aetiological forms of CP (alcoholic, idiopathic and tropical) and evaluated whether there were any differences between them. In all 
samples, the number of nerves, area of neural tissue, nerve size, and percentage of neural issue and perineural inflammatory cell 
infiltrates were analyzed histologically. In comparison with normal controls, all these parameters were significantly increased in all 
three forms of CP except the number of nerves in tropical CP. Despite this observation, the percentage of neural tissue was similar in 
all the three forms studied and this was primarily due to the fact that while the number of nerves was not increased in tropical CP, the 
size of the individual nerves was bigger in tropical CP than alcoholic and idiopathic CP. When the degree of perineural inflammation 
was evaluated, no difference was observed among the three groups. Thus, it was concluded that independent of the underlying 
aetiology, CP is associated with an increase in neural tissue and neural alterations occur in a similar fashion irrespective of the type of 
initiating event 103. 
There is increasing evidence that immune mechanisms may be crucial in the development alcoholic CP. However, it is not 
known whether difference in the underlying aetiology influence the inflammatory reaction in patients with CP. In the second part of 
our study, the histological feature and the pattern of inflammatory cell infiltration were studied in three groups of CP. Haematoxylin 
and eosin-stained tissue sections were used for histological evaluation. For immunohistochmical characterization of the inflammatory 
reaction, 4 antibodies--- CD4, CD8, CD45 and CD68----were used. Quantitative evaluation of the various cell infiltrates was 
performed with computer -assisted image analysis. The inflammatory cell infiltration pattern was also evaluated. It was observed that 
the degree of endophlibitis and the overall density of plasma cells was greater in tropical CP than alcoholic CP. The grade of 
intralobular fibrosis was significantly higher in tropical CP compared with idiopathic CP. No significant quantitative difference in the 
specific cellular infiltrates (CD4, CD8, CD45, CD68) were observed in the three groups. It was thus concluded that different 
aetiological forms of CP result in similar histological feature and a comparable inflammatory cell reaction indicating that the disease, 
independent of the underlying aetiology, reaches a common immunological stage beyond which it appears to progress as a single 
distinctive entity.104 Additional information is now available on tropical CP. Chandak et al. Have demonstrated the importance of 
mutations in the SPINK1 gene in tropical CP.105 In India, mutation in the SPINK1 rather than the PRSS1 gene are significantly 
associated with tropical CP.105        
Genetic Basis of Pain in Chronic Pancreatitis:  
 
 Increased intraductal pressure as a result of single or multiple stricture and/or calculi is believed to be the cause of pain in 
patient with dilated main pancreatic duct disease. The other causes of pain are duodenal and common bile obstruction due to ongoing 
pancreatic inflammation and scarring. However, at the molecular level , the most recent concept of the pathogenesis of pain in CP 
postulates alteration in the pancreatic nerves and neuroimmune interactions as crucial in the development of Pin syndrome.106 In 
addition to the nerve changes described above in tropical CP, inflammatory cells have also been implicated in neural changes in CP, 
since infiltration of the pancreatic nerves by immune cells and destruction of the perineurium have correlated with the intensity of pain 
in CP.107 The recruitment of inflammatory cells in to the inflamed pancreatic tissue depends on the production of chemotactic factor. 
The pancreatic parenchyma is actively involved in the induction of inflammation in CP through the production of different kinds of 
chemokines. Among other, interleukin-8, ENA78 and MCP 1 have been localized at high levels in certain tissue compartment in CP. 
108   In addition, increased levels of RADTES, MIP-alpha and their receptor CCR 5, which is mainly expressed on infiltrating 
macrophages, have been observed in CP. 109 other factors such nerve growth factor  (NGF) and receptor TrkA are expressed at 
increased levels in CP NGF was observed in tubular complexes and in dedifferentiating Acinar cells in CP whereas TrkA was mainly 
present in the perineurium in CP. 110 Interestingly, there was a strong correlation between NGF levels and pancreatic fibrosis and 
Acinar cell damage, as well as between TrkA levels and pain intensity. 30 It was, therefore, suggested that the NGF/TrkA pathway 
might influence neural morphological changes in the pain syndrome in CP.   
 The other major players in the transmission of pain are neurotransmitters. The same group previously demonstrated 16 that 
the neurotransmitters substance P is increased in the intrapancreatic nerves in CP. However, substance P function via its specific 
receptor  
(NK-1R), and therefore determination of the presence of NK-1R and localization of the site of NK-1R gene expression is expected to 
provide further insight into substance P-mediated pathways. Thus, the expression of NK-1R mRNA was quantitatively studied and the 
site of its mRNA and protein expression localized. We also evaluated whether there is a relationship between the presence of NK-1R 
mRNA levels, and pain and inflammation in CP.NK-1R was localized in the enlarged intrapancreatic nerves, ganglia blood vessels 
and inflammatory cells. The NK-1RmRNA levels obtained by quantitative polymerase chain reaction (PCR) were also correlated with 
clinical parameters. This analysis revealed that expression of the NK-1R gene correlation significantly with the intensity, duration and 
frequency of pain, but not with the severity of pancreatic inflammation. 
 
 
 
 
ISLET CELL AUTOTRANSPLANTATION: 
 
  In one study, these patients, when treated with intrahepatic islet cell autotransplantation, did remarkably well (blood 
glucose <126 mg/d1, hemoglobin A1c 6.5%). Five of six patients did not require insulin therapy at all 111.The results of islet cell 
autotransplantation in the portal vein, within the spleen and portal vein or within the spleen alone are equally good. Even though 
patients require insulin, the dose needed to achieve normoglycemia is low. The embolisation technique has complication such as 
duodenal ischemia, splenic infarction and portal or splenic vein thrombosis. Even after surgery, over 15% of patients continue to 
experience pain and an end stage fibrotic gland and those dependent on narcotics do not do well after islet cell transplantation 112.  
 
 
 
  
 
 
 
 
SUMMARY 
 
 We determined long term outcome and early and late morbidity and mortality, respectively in 100 patients undergoing 
surgery for chronic pancreatitis from 1990 through 2004 and completed atleast six months follow-up during two years period (2003 – 
2004). The mean follow up was 43. 5 months. Majority of patients are tropical pancreatitis. Indications for operation were pain, 
(80%), suspicion of malignancy in 2%, complications involving adjacent organs (18%). Pseudocysts were present in 10% of patients. 
While the hospital morbidity was less (14.3 Vs 55.6%) after drainage operation than after pancreatic resections, there was no 
difference in hospital mortality (1.4 Vs 0 %). The best results with pain relief occurred after LR – LPJ (92.3%). The number of 
patients are able to work a function normally after surgery increased markedly (9 Vs 82%, P< 0.001).Late deaths occurred in four 
patients. Three patients had unsuspected pancreatic malignancy. One patient had developed G.I. bleed related to splenic artery pseudo 
aneurysm. Pancreatic insufficiency particularly diabetes mellitus improved significantly after surgery at follow-up of 3.6 years. There 
was significant reduction in insulin requirement and decrease in fasting and postprandial blood glucose levels. No significant 
improvement in exocrine insufficiency. There was no difference in changes in endocrine status between resection and drainage group.   
 
  
 
CONCLUSION 
 
 Operative treatment of chronic pancreatitis, when indicated can be performed safely with good results in terms of pain 
relief, weight gain and quality of life. Significant improvement in pancreatic endocrine insufficiency can be expected. Resectional 
procedures associated with higher early morbidity. Unsuspected malignancy is a common cause for late deaths. Continued use of 
Alcohol is associated with poor relief of pain and quality of life. Various genetic factors and genetic mechanisms have been identified 
and these may lead to the development of novel therapeutic strategies for the management of this particularly complex disease in the 
near feature, thereby improving the overall outcome.      
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Parameters Case1 Case2 Case 3 Case 4 Case 5 Case 6 Case7 Case 8 
Age/sex 57/M 25/F 28/F 38/F 21/M 45/M 54/M 53/M 
Etiology Alcohol Tropical Pancreas 
 divisum 
Tropical Tropical Alcohol Alcohol Alcohol 
Symptom  
Duration 
6 months 12 years 4 months 3 months 1 year 7 yrs 2 mon 3 yrs 
Indication 
For surgery 
Pseudocyst Pain Pain Jaundice Pseudocyst Pain ? Ca.  
Head 
GI Bleed 
Steatorrhea No No No No No No Yes No 
Analgesic use Injectable Injectable Oral Injectable Oral Oral Oral Oral 
Diabetes 
 Insulin (U) 
 OHA 
 Blood sugar (F/PP) 
Nil 
- 
Nil 
- 
Nil 
- 
Nil 
- 
Nil 
- 
Nil 
- 
Yes 
20 
- 
138/316 
Yes 
No 
Yes 
198/411 
Morphology  
MPD 
Ductal calculi 
Parenchymal 
Calcification 
Others 
 
8 mm 
+ 
+ 
 
- 
 
1 cm 
+ 
+ 
 
- 
 
7 mm 
+ 
- 
 
Pan. divisum 
 
3 cm 
+ 
- 
 
- 
 
1.1 cm 
+ 
+ 
 
- 
 
 
6 mm 
+ 
- 
 
- 
 
7 mm 
+ 
- 
 
Bulky 
head 
 
4 mm 
- 
- 
 
Cyst in head 
6x3 cm 
Blood clots+ 
Associated  
Complications 
Pseudocyst Abscess Tail GSD CBD  
stricture 
 
Pseudocyst Abscess 
Body & 
Tail 
- GDA Pseudo 
Aneurysm 
 
Interventions 
   Endoscopic 
   Surgical 
 
Nil 
LPJ +Cysto- 
jejunostomy 
 
Nil 
DP + PJ 
 
Nil 
LPJ + Chole 
 
Nil 
LPJ + CDD 
 
Nil 
LPJ 
 
Nil 
DP 
 
Nil 
PD 
 
Nil 
Excision of  
Pseudoaneur- 
ysm with PJ 
Postoperative  
Complications 
Wound 
 infection 
Nil Nil Nil Nil Nil Nil Pancreatic  
Fistula –  
Conser. Mx 
Follow-up 
  Pain relief 
  Weight gain 
   Steatorrhea 
   Req. for enzymes 
   Req. for Insulin (U) 
   Req. for OHA 
  GTT/ Bl. sugar (F/PP) 
  Alcohol withdrawal 
   Employment status 
   Rehospitalisation 
     
   Reoperation 
   Overall assessment 
   Outcome 
   Follow-up period 
 
Fair 
4 Kg+ 
Occasional 
No 
20 
No 
Control 
Yes 
No 
1-Pain Abd 
(2/2k) 
Nil 
Good 
Alive 
7 years 
 
Fair 
3 Kg+ 
No 
No 
50 
No 
Control 
NA 
No 
No 
 
No 
Good 
Alive  
7 years 
 
Good 
4 Kg+ 
No 
No 
No 
No 
Normal 
NA 
No 
No 
 
No 
Good 
Alive 
5 years 
 
Good 
4 Kg+ 
No 
No 
No 
No 
Normal 
NA 
Yes 
Pain abd. 
 
No 
Good 
Alive 
7 years 
 
 
Good 
5 Kg+ 
No 
No 
No 
No 
Normal 
NA 
Yes 
No 
 
No 
Good 
Alive 
5 yrs 
 
Good 
4 Kg+ 
No 
No 
No 
Yes 
Control 
Yes 
Yes 
No 
 
No 
Good 
Alive 
6 yrs 
 
Good 
2 Kg+ 
Yes 
Yes 
No 
Yes 
126/214 
Yes 
Yes 
No 
 
No 
Good 
Alive 
8 yrs 
 
Good 
4 Kg+ 
No 
No 
No 
No 
112/136   
Yes 
Yes 
No 
 
No 
Good 
Alive 
1 1/2 Yrs 
 
 
 
 
Parameters Case 9 Case 10 Case 11 Case 12 Case 13 Case 14 Case 15 Case 16 
Age/sex 40/M 64/M 52/M 39/M 48/F 49/M 57/M 32/F 
Etiology Alcohol Tropical Alcohol Alcohol Tropical Alcohol Hereditary Tropical 
Symptom  
Duration 
1 month 1 year 1 month 5 yrs 1 year 1 mo 1 mon 1 mo 
Indication 
For surgery 
Jaundice Pain Pain Jaundice Pseudocyst Jaundice Jaundice Pain 
Steatorrhea No No No No Yes No Yes No 
Analgesic use Injectable Injectable Injectable oral Oral Oral Oral Injectable 
Diabetes Yes Yes Yes Yes Yes Yes Yes Yes 
 Insulin (U) 
 OHA 
 Blood Sugar (F/PP) 
No 
Yes 
73/228 
No 
Yes 
144/276 
No 
No 
124/192 
35 
No 
272/360 
No 
Yes 
140/250 
No 
Yes 
225/310 
45 
No 
190/356 
45 
No 
188/280 
Morphology  
MPD 
Ductal calculi 
Parenchymal 
Calcification 
Others 
 
3 cm 
+ 
+ 
 
Mass Neck  
Atrophied 
Pancreas 
 
1 cm 
+ 
+ 
 
Atrophied 
Pancreas 
 
1 cm 
+ 
- 
 
- 
 
7 mm 
- 
- 
 
Bulky head 
4.7 cm 
 
7 mm 
+ 
+ 
 
- 
 
 
8 mm 
+ 
+ 
 
Atrophy 
 
1 cm 
+ 
- 
 
- 
 
2.5 cm 
- 
- 
 
- 
Associated  
Complications 
CBD  
Stricture 
Abscess  
Body& Tail 
GSD CBD  
stricture 
 
Abscess  
Body 
CBD 
Stricture 
CBD 
Stricture 
- 
Interventions 
   Endoscopic 
   Surgical 
 
Nil 
LPJ +CDD 
 
Nil 
DP + LPJ 
 
Nil 
PG +  
Chole 
 
Nil 
LPJ + CDD 
 
Nil 
LPJ + 
Ext.  
drainage 
 
Nil 
LPJ + 
CDD 
 
Nil 
LPJ + 
CDD 
 
Nil 
LPJ 
Postoperative  
Complications 
Nil Nil Nil Nil Nil Nil Nil Nil 
Follow-up 
  Pain relief 
  Weight gain 
   Steatorrhea 
   Req. for enzymes 
   Diabetic status 
   Req. for Insulin(U) 
   Req. for OHA 
  GTT/ Blood sugar 
  Alcohol withdrawal 
   Employment status 
   Rehospitalisation 
     
   Reoperation 
  
  Overall assessment 
   Outcome 
   Follow-up period 
 
Poor 
20 Kg loss 
No 
No 
No 
No 
No 
86/126 
Yes 
No 
2-Vomiting 
&Pain Abd 
1-Dissem.Ca.head 
GOO - GJ done 
Poor 
Died 
11/2  yrs 
 
Good 
3 Kg+ 
No 
No 
Yes 
No 
Yes 
128/189 
NA 
No 
No 
 
No 
 
Good 
Alive  
5 years 
 
Good 
4 Kg+ 
No 
No 
Yes 
No 
No 
106/148 
NA 
No 
No 
 
No 
 
Good 
Alive 
5 years 
 
Good 
7 Kg+ 
No 
No 
Yes 
No 
Yes 
162/242 
Yes 
Yes 
No. 
 
No 
 
Good 
Alive 
8 years 
 
 
Fair 
9 Kg+ 
Yes 
Yes 
Yes 
No 
Yes 
164/244 
NA 
No 
No 
 
No 
 
Good 
Alive 
9 yrs 
 
Fair 
7 Kg+ 
No 
No 
Yes 
No 
Yes 
146/234 
Yes 
Yes 
No 
 
No 
 
Good 
Alive 
8 yrs 
 
Fair 
3 Kg+ 
No 
No 
Yes 
No 
Yes 
156/234 
NA 
Yes 
No 
 
No 
 
Good 
Alive 
11 yrs 
 
Fair 
Same 
No 
No 
Yes 
10 
No 
148/282 
NA 
Yes 
No 
 
No 
 
Good 
Alive 
13 Yrs 
 
 
 
 
 
 
Parameters Case 17 Case 18 Case 19 Case 20 Case 21 Case 22 Case 23 Case 24 
Age/sex 44/F 30/F 28/F 25/M 32/M 19/M 28/M 30/M 
Etiology Tropical Tropical Tropical Tropical Alcohol Hereditary Tropical Tropical 
Symptom  
Duration 
18 mo 1 year 1 Yr 2 yrs 3 mon 3 yrs 5 year 4 mo 
Indication 
For surgery 
Pain Pain Pain Pain Pain Pain Pain Pain 
Steatorrhea No No No No No No Yes No 
Analgesic use Injectable Injectable Injectable Injectable Injectable Injectable Oral Injectable 
Diabetes 
 Insulin (U) 
 OHA 
Blood sugar (F/PP) 
No 
No 
Yes 
85/180 
Yes 
40 
No 
330/458 
Yes 
55 
No 
246/348 
Yes 
45 
No 
276/412 
Yes 
No 
Yes 
208/352 
Yes 
54 
No 
248/382 
Yes 
45 
No 
170/295 
Yes 
12 
No 
192/332 
Morphology  
MPD 
Ductal calculi 
Parenchymal 
Calcification 
Others 
 
1 cm 
+ 
- 
 
- 
 
9 mm 
+ 
- 
 
Pseudocyst 
Head 2x3 cm 
 
1 cm 
+ 
- 
 
- 
 
1 cm 
+ 
- 
 
PD Stricture 
At Body  
 
1 cm 
+ 
+ 
 
- 
 
 
9 mm 
+ 
+ 
 
Uncinate  
stones 
 
8 mm 
+ 
+ 
 
Atrophy 
 
 
1.5 cm 
+- 
+ 
 
- 
Associated  
Complications 
Nil Ileocaecal  
Mass 
Nil Nil 
 
Nil Nil Nil Nil 
Interventions 
   Endoscopic 
   Surgical 
 
Nil 
LPJ 
 
Nil 
LPJ + 
Enteroent- 
ostomy 
 
Nil 
LPJ 
 
Nil 
LPJ  
 
Nil 
LPJ  
 
Nil 
LPJ 
 
Nil 
Puestow’s 
 
 
Nil 
LPJ 
Postoperative  
Complications 
Nil Nil Nil Nil Nil Nil Nil Nil 
Follow-up 
  Pain relief 
  Weight gain 
   Steatorrhea 
   Req. for enzymes 
   Diabetic status 
   Req. for Insulin(U) 
   Req. for OHA 
  GTT/ Blood sugar 
  Alcohol withdrawal 
   Employment status 
   Rehospitalisation     
   Reoperation 
   Overall assessment 
   Outcome 
   Follow-up period 
 
Good 
4 Kg+ 
No 
No 
No 
No 
No 
112/156 
NA 
No 
1-Pain Abd 
Nil 
Good 
Alive 
14 yrs 
 
Fair 
5 Kg+ 
No 
No 
Yes 
No 
Yes 
169/302 
NA 
No 
No 
No 
Good 
Alive  
15 yrs 
 
Fair 
5 Kg+ 
No 
No 
Yes 
No 
Yes 
158/248 
NA 
No 
1-Abd. Pain 
No 
Good 
Alive 
4 years 
 
Good 
7 Kg+ 
No 
No 
Yes 
20 
No 
146/262 
NA 
Yes 
No. 
No 
Good 
Alive 
15 Yrs 
 
 
Good 
5 Kg+ 
No 
Yes 
Yes 
No 
Yes 
164/224 
NA 
Yes 
No 
No 
Good 
Alive 
14 yrs 
 
Good 
same 
No 
No 
Yes 
37 
No 
196/294 
Yes 
Yes 
No 
No 
Good 
Alive 
12 yrs 
 
Good 
3 Kg+ 
No 
No 
Yes 
10 
No 
230/298 
NA 
Yes 
No 
No 
Good 
Alive 
12 yrs 
 
Good 
3 Kg+ 
No 
No 
Yes 
No 
Yes 
136/264 
NA 
Yes 
No 
No 
Good 
Alive 
4 Yrs 
 
 
 
 
 
 
 
 
 
 
Parameters Case 25 Case 26 Case 27 Case 28 Case 29 Case 30 Case 31 Case 32 
Age/sex 27/M 27/M 35/F 35/M 22/M 33/F 42/M 48/M 
Etiology Tropical Tropical Tropical Alcohol Tropical Tropical Alcohol Alcohol 
Symptom  
Duration 
1 mo 2 yrs 3 mo 8 mo 2 ½ Yrs 5 mo  1 mo 15 yrs 
Indication 
For surgery 
Pain Pain Pain Pain Pain Pain Pain Pain 
Steatorrhea No No No No No No No No 
Analgesic use Injectable Injectable Injectable Injectable Injectable Injectable Injectable Injectable 
Diabetes 
 Insulin (U) 
 OHA 
 Blood sugar (F/PP) 
Yes 
12 
No 
266/348 
Yes 
12 
No 
198/340 
Yes 
No 
Yes 
180/312 
Yes 
No 
Yes 
154/299 
Yes 
8 
No 
124/220 
Yes 
30 
No 
242/320 
Yes 
16 
No 
222/334 
Yes 
45 
No 
240/396 
Morphology  
MPD 
Ductal calculi 
Parenchymal 
Calcification 
Others 
 
1 cm 
+ Head 
- 
 
Atrophy 
 
7 mm 
+ 
- 
 
- 
 
1 cm 
+ 
- 
 
- 
 
1 cm 
+ 
+ 
 
-  
 
1 cm 
+ 
+ 
 
- 
 
 
6 mm 
+ 
- 
Atrophy 
Pus in PD 
 
1.5 cm 
+ 
+ 
 
Head mass 
 
8 mm 
+ 
+ 
 
Pus in PD 
Associated  
Complications 
Nil Nil Nil Nil 
 
Nil Miliary  
Abd. TB 
Nil Nil 
Interventions 
   Endoscopic 
   Surgical 
 
Nil 
LPJ 
 
Nil 
LPJ  
 
Nil 
LPJ 
 
Nil 
LPJ  
 
Nil 
LPJ  
 
Nil 
LPJ 
 
Nil 
LPJ 
 
 
Nil 
LPJ 
Postoperative  
Complications 
Nil Nil Nil Nil Nil Nil Nil Nil 
Follow-up 
  Pain relief 
  Weight gain 
   Steatorrhea 
   Req. for enzymes 
   Diabetic status 
   Req. for Insulin(U) 
   Req. for OHA 
  GTT/ Blood sugar 
  Alcohol withdrawal 
   Employment status 
   Rehospitalisation     
   Reoperation 
   Overall assessment 
   Outcome 
   Follow-up period 
 
Good 
12 Kg+ 
No 
No 
No 
No  
No 
100/346 
NA 
Yes 
Nil 
Nil 
Good 
Alive 
3 yrs 
 
Good 
12 Kg+ 
Occasional 
No 
Yes 
12 
No 
154/272 
NA 
Yes 
No 
No 
Good 
Alive  
3 yrs 
 
Good 
3 Kg+ 
No 
No 
No 
No 
No 
104/136 
NA 
Yes 
No 
No 
Good 
Alive 
3 years 
 
Good 
5 Kg+ 
No 
No 
Yes 
No 
Yes 
172/264 
Yes 
Yes 
No. 
No 
Good 
Alive 
1 Yr 
 
 
Good 
5 Kg+ 
No 
Yes 
Yes 
8 
No 
134/214 
NA 
Yes 
No 
No 
Good 
Alive 
3  yrs 
 
Good 
3 Kg+ 
No 
No 
Yes 
No 
Yes 
128/236 
NA 
Yes 
No 
No 
Good 
Alive 
3 yrs 
 
Good 
7 Kg+ 
No 
No 
Yes 
No 
Yes 
140/274 
Yes 
Yes 
No 
No 
Good 
Alive 
4 yrs 
 
Good 
5 Kg+ 
No 
No 
Yes 
No 
Yes 
148/252 
Yes 
Yes 
No 
No 
Good 
Alive 
2 Yrs 
 
 
 
 
 
 
 
 
 
Parameters Case 33 Case 34 Case 35 Case 36 Case 37 Case 38 Case 39 Case 40 
Age/sex 40/M 51/M 34/M 32/F 59/M 28/F 55/F 31/F 
Etiology Alcohol Alcohol Tropical Tropical Tropical Tropical Tropical Tropical 
Symptom  3 yrs 1 ½ yrs. 7 yrs 10 yrs 3 mo 6 mo  3 yrs 2 yrs 
Duration 
Indication 
For surgery 
Pain Pain Pain Pain Pain Pain Pain Pain 
Steatorrhea No Yes No No No No No No 
Analgesic use Injectable Injectable Injectable Injectable Injectable Injectable Injectable Injectable 
Diabetes 
 Insulin(U) 
 OHA 
Blood sugar (F/PP) 
Yes 
No 
Yes 
134/258 
Yes 
46 
No 
188/332 
Yes 
45 
No 
205/376 
Yes 
No 
Yes 
196/278 
Yes 
30 
No 
248/372 
No 
No 
No 
- 
Yes 
45 
No 
236/398 
Yes 
No 
Yes 
194/346 
Morphology  
MPD 
Ductal calculi 
Parenchymal 
Calcification 
Others 
 
1.5 cm 
+ Head 
+ 
 
Atrophy 
 
1 cm 
+ 
+ 
 
Atrophy 
Head mass 
 
 
1.2 cm 
+ 
+ 
 
Atrophy 
Head mass 
 
8 mm 
+ 
+ 
 
Atrophy 
Head mass  
 
9 mm 
+ 
+ 
 
Head mass 
? Ca. 
 
 
1 cm 
+ 
+ 
 
Atrophy 
 
 
6  mm 
+ 
- 
 
- 
 
1 cm 
+ 
+ 
 
- 
Associated  
Complications 
Nil Pseudocyst 
head 
Nil Nil 
 
Nil Nil Nil Pseudocyst 
tail 
Interventions 
   Endoscopic 
   Surgical 
 
Nil 
Frey’s 
 
Nil 
Frey’s  
 
Nil 
Frey’s 
 
Nil 
Frey’s 
 
Nil 
Frey’s  
 
Nil 
LPJ 
 
Nil 
LPJ 
 
 
Nil 
LPJ 
Postoperative  
Complications 
Nil Nil Nil Nil Nil Nil Atelectasis Wound  
infection 
Follow-up 
  Pain relief 
  Weight gain 
   Steatorrhea 
   Req. for enzymes 
   Diabetic status 
   Req. for Insulin 
   Req. for OHA 
  GTT/ Blood sugar 
  Alcohol withdrawal 
   Employment status 
   Rehospitalisation     
   Reoperation 
   Overall assessment 
   Outcome 
   Follow-up period 
 
Good 
3 Kg+ 
No 
No 
Yes 
No 
Yes 
128/238 
Yes 
Yes 
Nil 
Nil 
Good 
Alive 
1 yr. 
 
Good 
4 Kg+ 
Occasional 
No 
Yes 
12 
No 
152/246 
Yes 
Yes 
No 
No 
Good 
Alive  
1 yr 
 
Good 
4 Kg+ 
No 
No 
Yes 
10 
No 
135/226 
NA 
Yes 
No 
No 
Good 
Alive 
1 year 
 
Good 
same 
No 
No 
Yes 
12 
No 
168/284 
NA 
Yes 
No. 
No 
Good 
Alive 
1 Yr 
 
 
Good 
2 Kg+ 
No 
Yes 
Yes 
No 
Yes 
164/278 
NA 
Yes 
No 
No 
Poor 
Death 
10 months 
Ca.head 
 
Good 
3 Kg+ 
No 
No 
No 
No 
No 
- 
NA 
Yes 
No 
No 
Good 
Alive 
4 yrs 
 
Good 
3 Kg+ 
No 
No 
Yes 
No 
Yes 
174/246 
NA 
Yes 
No 
No 
Good 
Alive 
5 yrs 
 
Good 
3 Kg+ 
No 
No 
Yes 
No 
Yes 
146/258 
NA 
Yes 
No 
No 
Good 
Alive 
1 Yr 
 
 
 
 
 
 
 
 
 
 
Parameters Case 41 Case 42 Case 43 Case 44 Case 45 Case 46 Case 47 Case 48 
Age/sex 30/M 21/F 30/M 26/F 43/F 50/M 24/M 35/M 
Etiology Tropical Tropical Tropical Tropical Tropical Alcohol Tropical Tropical 
Symptom  
Duration 
2 yrs 4 yrs. 1 yr 1 mo 12 yrs 3 mo  4 yrs 10 yrs 
Indication 
For surgery 
Pain Pain Pain Pain Pain Pain Pain Pain 
Steatorrhea Yes Yes No No No Yes No No 
Analgesic use Injectable Injectable Injectable Injectable Injectable Injectable Injectable Injectable 
Diabetes 
 Insulin(U) 
 OHA 
 Blood Sugar (F/PP) 
Yes 
18 
No 
229/378 
Yes 
56 
No 
304/412 
Yes 
21 
No 
228/338 
Yes 
20 
No 
222/278 
Yes 
30 
No 
282/384 
Yes 
45 
No 
312/482 
Yes 
No 
Yes 
105/220 
Yes 
No 
Yes 
176/288 
Morphology  
MPD 
Ductal calculi 
Parenchymal 
Calcification 
Others 
 
1 cm 
+ Head 
+ 
 
- 
 
8 mm 
+ 
+ 
 
Atrophy 
 
 
1 cm 
+ 
+ 
 
Atrophy 
 
 
7 mm 
- 
+ 
 
-  
 
4 mm 
+ 
+ 
 
Atrophy 
Head mass 
 
6 mm 
+ 
+ 
 
Atrophy 
 
 
1 cm 
+ 
- 
 
Pus in PD 
 
1.5 cm 
+ 
+ 
 
- 
Associated  
Complications 
Nil Nil Nil Nil 
 
Nil Nil Nil Nil 
Interventions 
   Endoscopic 
   Surgical 
 
Nil 
LPJ 
 
Nil 
LPJ  
 
Nil 
LPJ 
 
Nil 
LPJ 
 
Nil 
Frey’s  
 
Nil 
LPJ 
 
Nil 
Puestow’s 
 
Nil 
LPJ 
Postoperative  
Complications 
Nil Atelectasis Nil Wound  
infection 
Nil Wound 
infection 
Nil Wound  
infection 
Follow-up 
  Pain relief 
  Weight gain 
   Steatorrhea 
   Req. for enzymes 
   Diabetic status 
   Req. for Insulin(U) 
   Req. for OHA 
  GTT/ Blood sugar 
  Alcohol withdrawal 
   Employment status 
   Rehospitalisation     
   Reoperation 
   Overall assessment 
   Outcome 
   Follow-up period 
 
Good 
3 Kg+ 
No 
No 
Yes 
No 
Yes 
138/272 
NA 
Yes 
Nil 
Nil 
Good 
Alive 
1 yr. 
 
Good 
2 Kg+ 
Occasional 
No 
Yes 
20 
No 
186/248 
NA 
Yes 
No 
No 
Good 
Alive  
1 yr 
 
Good 
9 Kg+ 
No 
No 
Yes 
No 
Yes 
166/234 
NA 
Yes 
No 
No 
Good 
Alive 
2 yrs 
 
Good 
3 kg loss 
No 
Yes 
Yes 
No 
Yes 
158/256 
NA 
Yes 
No. 
No 
Fair 
Alive 
1 1/2  Yr 
 
 
Good 
4 Kg+ 
No 
No 
Yes 
No 
Yes 
148/238 
NA 
Yes 
No 
No 
Good 
Alive 
3 yrs 
 
Poor 
2 Kg loss 
No 
No 
Yes 
No 
Yes 
182/268 
Yes 
Yes 
No 
No 
Fair 
Alive 
1 1/2 yrs 
 
Fair 
6 Kg+ 
No 
No 
No 
No 
No 
98/124 
NA 
Yes 
No 
No 
Good 
Alive 
12 yrs 
 
Good 
4 Kg+ 
No 
No 
Yes 
No 
Yes 
136/218 
NA 
Yes 
No 
No 
Good 
Alive 
3 Yrs 
 
 
 
 
 
Parameters Case 49 Case 50 Case 51 Case 52 Case 53 Case 54 Case 55 Case 56 
Age/sex 52/M 33/M 18/F 34/M 35/M 32/M 40/M 43/M 
Etiology Alcohol Tropical Tropical Alcohol Tropical Tropical Tropical Alcohol 
Symptom  
Duration 
1 yrs 1 yr. 2 yrs 2 mo 1 mo 3 yrs  3 mo 5 yrs 
Indication Pain Pain Pain Pain Pain Pain Pain ? 
For surgery Malignancy 
Steatorrhea No Yes No No Yes Yes No Yes 
Analgesic use Injectable Injectable Injectable Injectable Injectable Injectable Injectable Oral 
Diabetes 
 Insulin (U) 
 OHA 
 Blood sugar (F/PP) 
Yes 
18 
No 
246/312 
Yes 
12 
No 
205/325 
Yes 
No 
Yes 
236/318 
Yes 
No 
Yes 
144/296 
Yes 
No 
Yes 
198/316 
Yes 
12 
No 
118/200 
No 
- 
- 
- 
No 
- 
- 
- 
Morphology  
MPD 
Ductal calculi 
Parenchymal 
Calcification 
Others 
 
1.2 cm 
+  
+ 
 
- 
 
1 cm 
+ 
+ 
 
Atrophy 
 
 
1 cm 
+ 
- 
 
Strictures at 
Body & Tail 
 
8 mm 
+ 
- 
 
-  
 
5 mm 
+ 
+ 
 
Atrophy 
Head mass 
 
9 mm 
+ 
+ 
 
Atrophy 
 
 
3 cm 
+ 
- 
 
Pus in PD 
 
4 mm 
- 
+ 
Head mass  
6x5 cm 
Atrophy- 
Associated  
Complications 
Pseudocyst 
head 
Nil Nil Nil 
 
Nil Nil Nil Nil 
Interventions 
   Endoscopic 
   Surgical 
 
Nil 
LPJ 
 
Nil 
LPJ  
 
Nil 
LPJ 
 
Nil 
LPJ 
 
Nil 
Frey’s  
 
Nil 
LPJ 
 
Nil 
LPJ 
 
Nil 
Whipple’s 
Postoperative  
Complications 
Nil Nil Nil Nil Nil Nil Gastropare- 
sis 
Bile leak 
operated 
Follow-up 
  Pain relief 
  Weight gain 
   Steatorrhea 
   Req. for enzymes 
  Diabetic status 
  Req. for Insulin (U) 
   Req. for OHA 
  GTT/ Blood sugar 
  Alcohol withdrawal 
   Employment status 
   Rehospitalisation     
   Reoperation 
   Overall assessment 
   Outcome 
   Follow-up period 
 
Good 
3 Kg+ 
No 
No 
No 
No 
No 
96/126 
Yes 
Yes 
Nil 
Nil 
Good 
Alive 
1 yr. 
 
Good 
21 Kg loss 
Yes 
Yes 
No 
No 
No 
96/128 
NA 
Yes 
No 
No 
Fair 
Alive  
3 yrs 
 
Good 
4 Kg+ 
No 
No 
Yes 
No 
Yes 
136/224 
NA 
Yes 
No 
No 
Good 
Alive 
1 yr 
 
Good 
4 Kg+ 
No 
No 
Yes 
No 
Yes 
146/244 
Yes 
Yes 
No 
No 
Good 
Alive 
8  Yrs 
 
 
Good 
5 Kg+ 
Yes 
Yes 
Yes 
No 
Yes 
142/278 
NA 
Yes 
No 
No 
Good 
Alive 
3 yrs 
 
Fair 
5 Kg+ 
Yes 
Yes 
Yes 
No 
Yes 
128/216 
NA 
Yes 
No 
No 
Good 
Alive 
3 yrs 
 
Poor 
4 Kg loss 
No 
No 
No 
No 
No 
Normal 
NA 
No 
No 
No 
Poor 
Dead 
1 yrs 
Ca.head 
 
Good 
1 Kg loss 
Yes 
Yes 
No 
No 
No 
Normal 
Yes 
Yes 
No 
No 
Good 
Alive 
1 Yr 
 
 
 
 
 
 
 
 
 
 
 
 
Parameters Case 57 Case 58 Case 59 Case 60 Case 61 Case 62 Case 63 Case 64 
Age/sex 25/M 55/M 55/M 12/M 24/F 13/M 38/M 22/F 
Etiology Tropical Alcohol Tropical Tropical Tropical Tropical Alcohol Tropical 
Symptom  
Duration 
7 yrs 10 mo 5 yrs 2 yrs 4 mo 3 yrs  3 Yrs 2 yrs 
Indication 
For surgery 
Pain Pain Pain Pain Pancreatic 
Ascites 
Pancreatic 
Ascites 
Pancreatic 
Ascites 
Pain 
Steatorrhea No No No No Yes Yes Yes Yes 
Analgesic use Injectable Injectable Injectable Injectable Injectable Injectable Injectable Injectable 
Diabetes 
 Insulin 
 OHA 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
Morphology  
MPD 
Ductal calculi 
Parenchymal 
Calcification 
Others 
 
1 cm 
+  
+ 
 
Head mass 
 
2 cm 
+ 
+ 
 
Head mass 
 
4 mm 
+ 
+ 
 
Head mass 
Necrosis+ 
 
9 mm 
+ 
- 
 
Head mass  
 
8 mm 
+ 
+ Head 
 
Ductal dis- 
ruptions 
 
7 mm 
+ 
+ 
 
Ductal dis- 
ruptions 
 
 
7 mm 
+ 
+ 
Duct disru- 
ption Tail 
Stricture  
Neck 
 
4 mm 
+ 
+ 
 
Head mass  
 
Associated  
Complications 
Nil Nil Nil Nil 
 
Ascites Ascites Ascites Pseudocyst 
head 
Interventions 
   Endoscopic 
   Surgical 
 
Nil 
Frey’s 
 
Nil 
Frey’s 
 
Nil 
Frey’s 
 
Nil 
Frey’s 
 
Nil 
PG  
 
Nil 
PG 
 
Nil 
DP + PJ 
 
Nil 
Frey’s 
Postoperative  
Complications 
Nil Nil Pancreatic  
Leak 
Nil Nil Nil Pancreatic 
leak 
Nil 
Follow-up 
  Pain relief 
  Weight gain 
   Steatorrhea 
   Req. for enzymes 
   Diabetic status 
   Req. for Insulin 
   Req. for OHA 
  GTT/ Blood sugar 
  Alcohol withdrawal 
   Employment status 
   Rehospitalisation     
   Reoperation 
   Overall assessment 
   Outcome 
   Follow-up period 
 
Good 
4 Kg+ 
No 
No 
No 
No  
No 
Normal 
NA 
Yes 
Nil 
Nil 
Good 
Alive 
6 mo 
 
Good 
4 Kg+ 
No 
Yes 
No 
No  
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive  
1 1/2 yrs 
 
Good 
8 Kg+ 
No 
No 
No 
No 
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive 
2 yrs 
 
Good 
4 Kg+ 
No 
No 
No 
No 
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive 
1  Yr 
 
 
Good 
3 Kg+ 
No 
No 
No 
No 
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive 
7 mo 
 
Good 
4 Kg+ 
No 
No 
No 
No 
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive 
1 yr 
 
Good 
3 Kg loss 
No 
No 
No 
No 
No 
Normal 
Yes 
No 
No 
No 
Good 
Alive 
9 mo 
 
Good 
2 Kg+ 
No 
Yes 
No 
No 
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive 
6 mo 
 
 
 
 
 
 
 
 
Parameters Case 65 Case 66 Case 67 Case 68 Case 69 Case 70 Case 71 Case 72 
Age/sex 43/M 31/M 28/M 31/F 25/M 18/M 22/M 36/M 
Etiology Alcohol Tropical Tropical Tropical Tropical Tropical tropical Alcohol 
Symptom  
Duration 
1 yr 11 yrs 20 yrs 2 yrs 3 mo 4 yrs  5 Yrs 6 mo 
Indication 
For surgery 
Pain Pain Pain Pain Pain Pain Pain Pain 
Steatorrhea No No No No No No No No 
Analgesic use Injectable Injectable Injectable Injectable Injectable Injectable Injectable Injectable 
Diabetes 
 Insulin 
 OHA 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
Morphology  
MPD 
Ductal calculi 
Parenchymal 
Calcification 
Others 
 
1 cm 
+  
+ 
 
Head mass 
Pus in PD 
 
1 cm 
+ 
+ 
 
Atrophy 
Stent in PD  
In situ 
 
2.5 cm 
+ 
+ 
 
Pus in PD 
 
7 mm 
+ 
- 
 
-  
 
7 mm 
+ 
+ Head 
 
Stricture  
Body 
 
1.4 cm 
+ 
+ 
 
Atrophy 
 
 
7 mm 
+ 
+ 
 
- 
 
7 mm 
+ 
+ 
 
Atrophy  
 
Associated  
Complications 
Nil Nil Nil Nil 
 
Nil GB sludge Nil Nil 
Interventions 
   Endoscopic 
   Surgical 
 
Nil 
Frey’s 
 
PD stent 6 mo 
PG 
 
Nil 
LPJ 
 
Nil 
LPJ 
 
Nil 
LPJ  
 
Nil 
LPJ + 
 Chole 
 
Nil 
LPJ 
 
Nil 
LPJ 
Postoperative  
Complications 
UTI Nil Nil Nil Nil Nil Nil Nil 
Follow-up 
  Pain relief 
  Weight gain 
   Steatorrhea 
   Req. for enzymes 
  Diabetic status 
  Req. for Insulin 
   Req. for OHA 
  GTT/ Blood sugar 
  Alcohol withdrawal 
   Employment status 
   Rehospitalisation     
   Reoperation 
   Overall assessment 
   Outcome 
   Follow-up period 
 
Poor 
5 Kg loss 
Yes 
Yes 
No 
No  
No 
Normal 
Yes 
Yes 
1-Pain abd 
Nil 
Poor 
Alive 
2 yrs 
 
Good 
5 Kg+ 
No 
Yes 
No 
No  
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive  
3 yrs 
 
Poor 
4 Kg+ 
No 
No 
No 
No 
No 
Normal 
NA 
Yes 
2-Pain abd. 
No 
Fair 
Alive 
3 yrs 
 
Good 
6 Kg+ 
No 
No 
Yes 
No  
(diet control) 
Normal 
NA 
Yes 
No 
No 
Good 
Alive 
2 1/2  Yrs 
 
 
Good 
4 Kg+ 
No 
No 
No 
No 
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive 
3 yrs 
 
Good 
3 Kg+ 
No 
No 
No 
No 
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive 
1 yr 
 
Good 
4 Kg+ 
No 
No 
No 
No 
No 
Normal 
Yes 
No 
No 
No 
Good 
Alive 
1 ½ yrs 
 
Good 
3 Kg+ 
No 
No 
No 
No 
No 
Normal 
Yes 
Yes 
1-Pain abd 
No 
Fair 
Alive 
1 yr 
 
 
 
 
 
 
 
 
 
 
Parameters Case 73 Case 74 Case 75 Case 76 Case 77 Case 78 Case 79 Case 80 
Name Anbarasan Vasanthi Karpagam Anbarasi Arulkumar Bhabya Venkata Lavanya 
Age/sex 33/M 49/F 32/F 19/F 24/M 23/F 65/M 20/F 
Etiology Tropical Tropical Tropical Tropical Tropical Tropical tropical Tropical 
Symptom  
Duration 
1 mo 3  yrs 1 mo 4 yrs 2 mo 10 yrs 30 Yrs 1 yr 
Indication 
For surgery 
Pain Pain Pain Pain Pain Pain Pain Pain 
Steatorrhea No No No No No No No No 
Analgesic use Injectable Injectable Injectable Injectable Injectable Injectable Injectable Injectable 
Diabetes 
 Insulin 
 OHA 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
Morphology  
MPD 
Ductal calculi 
Parenchymal 
Calcification 
Others 
 
2 cm 
+  
+ 
 
- 
 
8 mm 
+ 
- 
 
- 
 
7 mm 
+ 
+ 
 
Strictures at 
Head+ 
 
9 mm 
+ 
+ 
 
-  
 
8 mm 
+ 
+ 
 
- 
 
8  mm 
+ 
+ 
 
- 
 
1.5 cm 
+ 
+ 
 
- 
 
6 mm 
+ 
+ 
 
-  
 
Associated  
Complications 
Nil Nil Nil Nil 
 
Nil Nil Nil Nil 
Interventions 
   Endoscopic 
   Surgical 
 
Nil 
LPJ 
Pancre. Sphin- 
Cterotomy+ 
LPJ 
 
Nil 
LPJ 
 
Nil 
LPJ 
 
Nil 
LPJ  
 
Nil 
LPJ 
 
Nil 
LPJ 
 
Nil 
LPJ 
Postoperative  
Complications 
Nil Nil Nil Nil Nil Nil Nil Nil 
Follow-up 
  Pain relief 
  Weight gain 
   Steatorrhea 
   Req. for enzymes 
   Diabetic status    
   Req. for Insulin 
   Req. for OHA 
  GTT/ Blood sugar 
  Alcohol withdrawal 
   Employment status 
   Rehospitalisation     
   Reoperation 
   Overall assessment 
   Outcome 
   Follow-up period 
 
Good 
4 Kg+ 
No 
No 
No 
No  
No 
Normal 
NA 
Yes 
No 
Nil 
Good 
Alive 
1 yr 
 
Fair 
same 
No 
No 
No 
No  
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive  
11/2 yr 
 
Good 
4 Kg+ 
No 
No 
No 
No 
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive 
1 ½ yrs 
 
Good 
3 Kg+ 
No 
No 
No 
No  
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive 
1 1/2  Yrs 
 
 
Good 
7 Kg+ 
No 
No 
No 
No 
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive 
1 yr 
 
Good 
3 Kg+ 
No 
No 
No 
No 
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive 
3 yrs 
 
Good 
same 
No 
No 
No 
No 
No 
Normal 
Yes 
No 
No 
No 
Good 
Alive 
10 mo 
 
Good 
4 Kg+ 
No 
No 
No 
No 
No 
Normal 
No 
Yes 
No 
No 
Good 
Alive 
10 mo 
 
 
Parameters Case 81 Case 82 Case 83 Case 84 Case 85 Case 86 
Age/sex 42/M 15/F 18/M 16/M 37/M 37/M 
Etiology Tropical Tropical Tropical Tropical Alcohol Alcohol 
Symptom  
Duration 
10 yrs 1 ½ yrs 6 mo 2 mo 2 yrs 1 yrs 
Indication for surgery Pain Biliary stenosis Pain GI Bleed Pain Pain 
Steatorrhea occasional Yes No No No No 
Analgesic use Injectable Oral Injectable Oral Injectable Injectable 
Diabetes 
 Insulin (U) 
 OHA 
 Blood sugar (F/PP) 
No 
- 
- 
- 
No 
- 
- 
- 
No 
- 
- 
- 
No 
- 
- 
- 
No 
- 
- 
- 
Yes 
45 
- 
318/456 
Morphology  
MPD 
Ductal calculi 
Parenchymal 
Calcification 
Others 
 
1 cm 
+  
+ 
 
- 
 
6 mm 
+ 
- 
 
Atrophy 
 
8 mm 
+ 
- 
 
Atrophy 
 
8 mm 
- 
- 
-  
 
4 mm 
- 
+ 
Multiple  
strictures 
 
 
1  cm 
+ 
+ 
 
PD Stent+ 
Associated  
Complications 
Nil CBD stricture Nil SA Pseudo- 
aneurysm 
bleed 
Pseudocyst 
Head  
3x2.5cm 
Nil 
Interventions 
   Endoscopic 
   Surgical 
 
Nil 
LPJ 
 
Nil 
LPJ + CDD 
 
Nil 
LPJ 
 
Nil 
Excision of  
Pseudoaneu- 
rysm with  
Central  
Pancreatectomy 
With PJ 
 
Nil 
Frey’s  
 
PD Stent 
LPJ 
Postoperative  
Complications 
Nil Nil Nil Nil Wound  
Dehiscence 
GI Bleed 
Operated  
Nil 
Follow-up 
  Pain relief 
  Weight gain 
   Steatorrhea 
   Req. for enzymes 
    Diabetic status 
   Req. for Insulin(U) 
   Req. for OHA 
  GTT/ Blood sugar 
  Alcohol withdrawal 
   Employment status 
   Rehospitalisation     
   Reoperation 
    
 
 
Overall assessment 
   Outcome 
   Follow-up period 
 
Good 
3 Kg+ 
No 
No 
No 
No  
No 
Normal 
NA 
Yes 
No 
Nil 
 
 
 
Good 
Alive 
7 mo 
 
Good 
4 Kg+ 
No 
No 
No 
No  
No 
Normal 
NA 
Yes 
No 
No 
 
 
 
Good 
Alive  
2 yrs 
 
Good 
3 Kg+ 
No 
No 
No 
No 
No 
Normal 
NA 
Yes 
No 
No 
 
 
 
Good 
Alive 
3 yrs 
 
Good 
4 Kg+ 
No 
No 
No 
No  
No 
Normal 
NA 
Yes 
No 
No 
 
 
 
Good 
Alive 
3  Yrs 
 
- 
- 
-- 
- 
- 
- 
- 
- 
- 
- 
- 
Reoperated 
Pancreatic bleed 
MODS 
 
 
 
Death 
 
 
Poor 
6 Kg loss 
Yes 
Yes 
Yes 
20 
No 
244/310 
No 
No 
Yes 
Ruptured Splenic Artery  
PseudoAneurysm 
 DP +Excision of PA 
Gastric perforation 
Closure +Transverse 
Colostomy 
Death – 6 months 
       
       
Parameters Case 87 Case 88 Case 89 Case 90 Case 91 Case 92 
Age/sex 31/M 43/M 43/M 36/M 12/F 43/M 
Etiology Alcohol Tropical Alcoholic Alcoholic Tropical Tropical 
Symptom  
Duration 
2 Yrs 2 mo 6 mo 6 mo 2 yrs 2 yrs 
Indication for surgery Pain Pain Pain Pain GI Bleed Haemoptysis & GI Bleed 
Steatorrhea No No No No No No 
Analgesic use Injectable Injectable Injectable Injectable Injectable Oral 
Diabetes 
 Insulin (U) 
 OHA 
Yes 
No 
Yes 
Yes 
35 
- 
Yes 
30 
No 
Yes 
12 
No 
No 
- 
- 
No 
- 
- 
 Blood sugar(F/PP) 76/96 346/416 378/476 195/350 - - 
Morphology  
MPD 
Ductal calculi 
Parenchymal 
Calcification 
Others 
 
1 cm 
+ 
+ 
 
- 
 
1 cm 
+ 
+ 
 
Pus in PD 
Atrophy 
 
6 mm 
+ 
+ 
 
- 
 
8 mm 
+ 
+ 
+ 
Atrophy 
 
5 mm 
- 
+ 
- 
 
1 cm 
+ 
 
 
- 
Associated  
Complications 
Nil Resolving 
Pseudocyst 
Lt. Subhepatic 
Nil Nil Splenic artery 
Pancreatic duct 
Communication 
Ruptured pseudocyst 
Intraperitoneal bleed  
Pseudoaneurysm of Splenic 
Artery eroding into 
Diaphragm, bronchus 
 and colon 
Interventions 
   Endoscopic 
   Surgical 
 
Nil 
LPJ 
 
Nil 
LPJ 
 
Nil 
LPJ 
 
Nil 
LPJ  
 
Nil 
DP+Roux-n-PJ 
 
ESWL + stenting done 
DP+ Excision of SA  
Pseudoaneurysm+ 
Closure of diaphragmatic 
And colonic rent 
Postoperative  
Complications 
Nil Nil Nil Nil Nil Nil 
Follow-up 
  Pain relief 
  Weight gain 
   Steatorrhea 
   Req. for enzymes 
   Diabetic status 
   Req. for Insulin 
   Req. for OHA 
  GTT/ Blood sugar 
  Alcohol withdrawal 
   Employment status 
   Rehospitalisation     
   Reoperation 
Overall assessment 
   Outcome 
   Follow-up period 
 
Good 
3 Kg+ 
No 
No 
Yes 
No 
Yes 
116/178 
Yes 
No 
No 
No 
Good 
Alive 
7 mo 
 
Good 
4 Kg+ 
No 
No 
Yes 
No 
Yes 
248/306 
No 
Yes 
No 
No 
Good 
Alive 
1 ½ Yrs 
 
Good 
5 Kg+ 
No 
No 
Yes 
No 
Yes 
236/318 
Yes 
No 
No 
No 
Good 
Alive 
2 Yrs 
 
Good 
4 Kg+ 
No 
No 
Yes 
No  
Yes 
146/212 
Yes 
Yes 
No 
No 
Good 
Alive 
2 ½  Yrs 
 
Good 
2 Kg+ 
No 
No 
 
No 
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive 
6 months 
 
Good 
3 Kg+ 
No 
No 
 
No 
No 
Normal 
NA 
Yes 
No 
Colostomy closure 
Good 
Alive 
1 yr. 
 
 
 
 
Parameters Case 93 Case 94 Case 95 Case 96 Case 97 Case 98 Case 99 Case 100 
Age/sex 52/M 49/M 55/M 35/M 46/F 66/M 23/F 31/M 
Etiology Tropical Alcohol Alcohol Alcohol Tropical Tropical Tropical Alcohol 
Symptom  
Duration 
3 mo 2 mo 3 yrs 1 yr 2 mo 4 mo 1 Yr 5 yrs 
Indication 
For surgery 
Pain Pain Pain Pain Pain Pseudocyst Pain GI Bleed 
Steatorrhea No No No No No No No No 
Analgesic use Injectable Injectable Injectable Injectable Injectable Injectable Injectable Injectable 
Diabetes 
 Insulin (U) 
 OHA 
 Blood sugar (F/PP) 
Yes 
No 
Yes 
135/234 
Yes 
8 
No 
136/324 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
No 
- 
- 
Morphology  
MPD 
Ductal calculi 
Parenchymal 
Calcification 
Others 
 
7 mm 
+  
- 
 
- 
 
1.2 cm 
+ 
+ 
 
- 
 
8 mm 
+ 
+ 
 
Atrophied 
 
9 mm 
+ 
+ 
 
Mass Tail & 
Body 
 
9 mm 
+ 
- 
 
Atrophy 
 
1 cm 
+ 
- 
- 
 
- 
 
1.5 cm 
+ 
- 
 
- 
 
6 mm 
- 
- 
 
Associated  
Complications 
Nil Nil Nil Nil 
 
Nil Pseudocyst 
Head + GSD 
Gallstone Splenic 
Artery Pse- 
udoaneurysm 
Pseudocyst 
Body  
Interventions 
   Endoscopic 
   Surgical 
 
Nil 
LPJ 
 
Nil 
LPJ 
 
Nil 
LPJ 
 
Nil 
LPJ 
 
Nil 
LPJ  
 
Nil 
LPJ +Cysto- 
Gastrostomy+ 
Chole 
 
Nil 
LPJ+ 
Chole 
 
Nil 
Transcystic 
Ligation of 
Bleeding  
Vessel 
Cystogas- 
trostomy 
Postoperative  
Complications 
Nil Nil Nil Nil Nil Nil Pancreatic 
leak 
Nil 
Follow-up 
  Pain relief 
  Weight gain 
   Steatorrhea 
   Req. for enzymes 
   Diabetic status 
   Req. for Insulin(U) 
   Req. for OHA 
  GTT/ Blood sugar 
  Alcohol withdrawal 
   Employment status 
   Rehospitalisation     
   Reoperation 
   Overall assessment 
   Outcome 
   Follow-up period 
 
Good 
3 Kg+ 
No 
No 
Yes 
No  
Yes 
116/229 
NA 
Yes 
No 
Nil 
Good 
Alive 
4 yrs 
 
Good 
4 Kg+ 
No 
No 
Yes 
No  
No 
118/168 
NA 
Yes 
No 
No 
Good 
Alive  
3 yrs 
 
Good 
4 Kg+ 
No 
No 
No 
No 
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive 
7 yrs 
 
Good 
4 Kg+ 
No 
No 
No 
No  
No 
Normal 
Yes 
Yes 
No 
No 
Good 
Alive 
3  Yrs 
 
 
Good 
3 Kg+ 
No 
No 
No 
No 
No 
Normal 
NA 
Yes 
No 
No 
Good 
Alive 
3  yrs 
 
Good 
4 Kg+ 
No 
No 
No 
No 
No 
Normal 
NA 
Yes 
1 - Incisional 
Hernia Repair 
Good 
Alive 
5 yrs 
 
Good 
4 Kg+ 
No 
No 
No 
No 
No 
Normal 
Yes 
No 
No 
No 
Good 
Alive 
5 yrs 
 
Good 
3 Kg+ 
No 
No 
No 
No 
No 
Normal 
No 
Yes 
No 
No 
Good 
Alive 
2 yrs 
 
 
  
 
 
